WO2007038997A1 - Two-component product for the treatment of keratin fibres - Google Patents

Abstract

The invention relates to a product for structuring and simultaneously caring for keratin fibres, comprising a two-component agent and a two-chamber dispenser, wherein the two-component agent comprises a first preparation (A), containing at least one filmogenic and/or fixing polymer and a second preparation (B), containing at least one care product and preparation (A) and preparation (B) are formulated in the chambers of the two-chamber dispenser and corresponding two-chamber dispenser.

Description

"Two-component product for the treatment of keratinic fibers"

The present invention relates to a two-component product for the treatment of keratinic fibers, consisting of a two-component agent and a two-chamber dispenser, and a corresponding two-chamber dispenser.

An attractive-looking hairstyle is now generally considered an indispensable part of a well-groomed appearance. Due to current fashion trends, hairstyles are always considered to be chic, which in many hair types can only be built up using firming agents or can be maintained for a longer period of time up to several days. Therefore, hair treatment agents that serve a permanent or temporary shaping of the hair play an important role. Temporary shapes, which should give a good grip, without affecting the healthy appearance of the hair, such as their gloss, can be achieved for example by hair sprays, hair waxes, hair gels, hair drier, etc.

Corresponding agents for ternary shaping usually contain synthetic polymers as the shaping component. Preparations containing a dissolved or dispersed polymer can be applied to the hair by means of propellant gases or by a pumping mechanism. In particular, however, hair gels and hair waxes are generally not applied directly to the hair, but distributed by means of a comb or hands in the hair.

A variety of special means have already been developed with which a wide variety of hairstyle types can be realized. Special attention has recently been paid to means that allow the structuring and emphasis of curly hair.

In particular, in the frequent use of means for temporary shaping, but also by other types of hair treatment, such as hair coloring, perms, the cleaning of the hair with shampoos and environmental pollution, it comes to the burden of treated hair, so that the importance of care products with possible long-lasting effect increases. Such care products affect the natural structure and properties of the hair. Thus, for example, following a treatment with a care product, the wet and dry combability of the hair, the hold, the firmness and the fullness of the hair can be optimized or the hair can be protected from increased split ends.

In order to achieve both a temporary hair deformation, as well as a nourishing effect, it is possible in principle, strengthening active ingredients, which are usually polymeric Compounds is to incorporate in conventional hair cleansing or conditioning agents containing the desired care products, or add usual means for temporary hair shaping care components. However, it has been shown that such a procedure has a number of disadvantages. Thus, the addition of the required amounts of care components to hair shaping agents leads to a drastic reduction of the firming effect. The addition of setting polymers to hair care products can not convince in terms of achievable strengthening properties and also has a negative effect on the care properties. In addition, both approaches often lead to problems with the stability of the formulations. It is therefore still the rule to use for structuring and emphasizing curly hair, a special agent that contains a firming polymer, and resort to the care of the hair on another means, such as a conventional hair conditioner or hair cure. This is associated with a correspondingly increased effort for the user.

The object of the present invention was therefore to provide a hair treatment agent for structuring and emphasizing curly hair, which not only gives an excellent and durable styling result, but also allows the simultaneous care of the treated hair.

It has now surprisingly been found that stable hair treatment compositions having excellent styling and conditioning effects can be obtained if an agent containing at least one setting component and an agent containing at least one care component are packaged separately from one another in a two-chamber dispenser.

A first subject of the present invention is therefore a product for the treatment of keratinic fibers consisting of a two-component agent and a two-chamber dispenser, wherein the two-component agent comprises a first preparation (A) comprising at least one film-forming and / or setting polymer, and a second preparation (B). containing at least one care substance comprises, and the two preparations are packaged separately from each other in the chambers of the bicameral dispenser.

The products of the invention are characterized by an excellent styling effect and good stability, at the same time a high care effect is achieved. The advantages are particularly evident in the structuring and emphasis on curly hair, in which a pronounced curl definition is achieved. The treated hair is also not sticky and is characterized by a soft feel. In addition, when using the products according to the invention it is ensured that the consumer applies the components of the two-component agent in the mixing ratio planned by the manufacturer. To this On the one hand, product safety is increased and, on the other hand, it is ensured that the product provides the desired performance.

The two-component agent of the product according to the invention can be applied to the fibers to be treated in various ways. In general, the two-component agent is removed from the two-chamber dispenser in the desired amount, optionally briefly mixed on the palm and then worked with his hands in the dry or damp hair. Surprisingly, despite the mixing of preparation (A) and preparation (B), no stability problems arise in this procedure and the structuring properties of the film-forming and / or setting polymer are retained.

Preparation (A) of the two-component agent contains at least one film-forming and / or setting polymer.

The film-forming and / or setting polymer is preferably contained in the two-component agent in an amount of from 1 to 15% by weight, more preferably from 1 to 10% by weight, most preferably in an amount of from 1 to 7% by weight based on the total two-component agent. Of course, several film-forming and / or setting polymers may be included in the two-component agent. These film-forming and / or setting polymers may be both permanent and temporary cationic, anionic, nonionic or amphoteric. Furthermore, the present invention also encompasses the recognition that, when using at least two film-forming and / or setting polymers, these can of course have different charges. It may be preferred according to the invention for an ionic film-forming and / or setting polymer to be used together with an amphoteric and / or nonionic film-forming and / or setting polymer. The use of at least two oppositely charged film-forming and / or setting polymers is also preferred. In the latter case, a particular embodiment may in turn additionally contain at least one further amphoteric and / or nonionic film-forming and / or setting polymer.

Since polymers are often multifunctional, their functions can not always be clearly and clearly distinguished from each other. This applies in particular to film-forming and setting polymers. Nevertheless, some film-forming polymers will be described by way of example. However, it is explicitly stated at this point that both film-forming and fixing polymers are essential in the context of the present invention. Since both properties are not completely independent of each other, the term "setting polymers" always "film-forming polymers" understood and vice versa. Among the preferred properties of the film-forming polymers is the film formation. Film-forming polymers are polymers which leave a continuous film on the skin, the hair or the nails when drying. Such film formers can be used in a wide variety of cosmetic products, such as for example face masks, make-up, hair fixatives, hair sprays, hair gels, hair waxes, hair treatments, shampoos or nail varnishes. Particular preference is given to those polymers which have sufficient solubility in alcohol or water / alcohol mixtures in order to be present in completely completely dissolved form in the agent according to the invention. The film-forming polymers may be of synthetic or natural origin.

According to the invention, film-forming polymers are understood as meaning polymers which, when used in 0.01 to 20% strength by weight aqueous, alcoholic or aqueous-alcoholic solution, are capable of depositing a transparent polymer film on the hair. The film-forming polymers may be anionic, amphoteric, nonionic, permanent cationic or temporarily cationically charged.

Suitable and inventively preferably used synthetic film-forming, hair-fixing polymers are homopolymers or copolymers which are composed of at least one of the following monomers: vinylpyrrolidone, vinylcaprolactam, vinyl esters such as vinyl acetate, vinyl alcohol, acrylamide, methacrylamide, alkyl and dialkylacrylamide, alkyl and Dialkyl methacrylamide, alkyl acrylate, alkyl methacrylate, propylene glycol or ethylene glycol, wherein the alkyl groups of these monomers are preferably C ₁ - to C ₇ alkyl groups, more preferably C ₁ - to C ₃ alkyl groups.

Examples include homopolymers of vinylcaprolactam, vinylpyrrolidone or N-vinylformamide. Further suitable synthetic film-forming, hair-fixing polymers are copolymers of vinyl pyrrolidone and vinyl acetate, terpolymers of vinylpyrrolidone, vinyl acetate and vinyl propionate, polyacrylamides, for example, under the trade designations Akypomine ^® P 191 by the company CHEM-Y, Emmerich or Sepigel ^® 305 by the company Seppic be distributed; Which are marketed under the trade names Elvanol.RTM ^® from DuPont or Vinol ^® 523/540 by Air Products polyvinyl alcohols as well as polyethylene glycol / polypropylene glycol copolymers, for example, under the trade names Ucon ^® Union Carbide sold. Preparation (A) of the two-component agent of the invention particularly preferably contains polyvinylpyrrolidone and / or polyvinylpyrrolidone / vinyl acetate copolymers.

Suitable natural film-forming polymers include cellulose derivatives, eg. B. hydroxypropyl cellulose having a molecular weight of 30,000 to 50,000 g / mol, which is sold for example under the trade name Nisso Sl ^® from Lehmann & Voss, Hamburg. Firming polymers contribute to the maintenance and / or build-up of the hair volume and hair fullness of the overall hairstyle. These so-called consolidating polymers are at the same time film-forming polymers and therefore generally typical substances for shaping hair treatment agents such as hair fixatives, hair mousse, hair waxes, hair sprays. The film formation can be quite selective and connect only a few fibers.

Substances which further impart hydrophobic properties to the hair are preferred because they reduce the tendency of the hair to absorb moisture, that is, water. As a result, the limp drooping of the strands of hair is reduced, thus ensuring a long-lasting hairstyle structure and preservation. The test method for this is often the so-called curl retention test applied. These polymeric substances can also be successfully incorporated into leave-on and rinse-off hair treatments or shampoos. Since polymers are often multifunctional, that is, show several applications-wise desirable effects, numerous polymers can be found in several groups on the mode of action, as well as in the CTFA Handbook. Because of the importance of polymers in particular, they should therefore be listed explicitly in the form of their INCI names. Of course, in this list of polymers which are very particularly preferred for use according to the invention, the above-mentioned film-forming polymers are also found again.

Examples of common film-forming, setting polymers are Acrylamide / Ammonium Acrylate Copolymer, Acrylamide / DMAPA Acrylates / Methoxy PEG Methacrylate Copolymer, Acrylamidopropyltrimonium Chloride / Acrylamide Copolymer, Acrylamidopropyltrimonium Chloride / Acrylates Copolymer, Acrylates / Acetoacetoxyethyl Methacrylate Copolymer, Acrylates / Acrylamide Copolymer, Acrylates / Ammonium Methacrylate Copolymer, Acrylates / t-Butylacrylamide Copolymer, Acrylates Copolymer, Acrylates / C1-2 Succinates / Hydroxy Acrylates Copolymer, Acrylates / Lauryl Acrylates / Stearyl Acrylates / Ethylamine Oxide Methacrylate Copolymer, Acrylates / Octylacrylamide Copolymer, Acrylates / Octylacrylamides / Diphenyl Amodimethicone Copolymer, Acrylates / Stearyl Acrylates / Ethylamine Oxides Methacrylate Copolymer, Acrylates / VA Copolymer, Acrylates / VP Copolymer, Adipic Acid / Diethylenetriamine Copolymer, Adipic Acid / Dimethylaminohydroxypropyl Diethylenetriamine Copolymer, Adipic Acid / Epoxypropyl Diethylenetriamine Copolymer, Adipic Ac id / Isophthalic Acid / Neopentyl Glycol / Trimethylolpropane Copolymer, Allyl Stearate / VA Copolymer, Aminoethyl Acrylate Phosphate / Acrylate Copolymer, Aminoethylpropanediol Acrylate / Acrylamide Copolymer, Aminoethyl Propanediol AMPD Acrylate / Diacetone Acrylamide Copolymer, Ammonium VA / Acrylate Copolymer, AMPD Acrylate / Diacetone Acrylamide Copolymer, AMP Acrylates / Allyl Methacrylate Copolymer, AMP Acrylates / CI-18 Alkyl Acrylates / C1-8 Alkyl Acrylamide Copolymer, AMP Acrylates / Diacetone Acrylamide Copolymer, AMP Acrylates / Dimethylaminoethyl Methacrylate Copolymer, Bacillus / Rice Bran Extract / Soybean Extract Ferment Filtrates, bis Butyloxyamodimethicone / PEG-60 Copolymer, Butyl Acrylate / Ethylhexyl Methacrylate Copolymer, Butyl Acrylate / Hydroxypropyl Dimethicone Acrylate Copolymer, Butylated PVP, Butyl Ester of Ethylene / MA Copolymer, Butyl Ester of PVM / MA Copolymer, Calcium / Sodium PVM / MA Copolymer, Com Starch / Acrylamide / Sodium Acrylate Copolymer, Diethylene Glycolamine / Epichlorohydrin / Piperazine Copolymer, Dimethicone Crosspolymer, Diphenyl Amodimethicone, Ethyl Ester of PVM / MA Copolymer, Hydrolyzed Wheat Protein / PVP Crosspolymer, Isobutylene / Ethylmaleimide / Hydroxyethylmaleimide Copolymer, Isobutylene / MA Copolymer , Isobutylmethacrylate / Bis-Hydroxypropyl Dimethicone Acrylate Copolymer, Isopropyl Ester of PVM / MA Copolymer, Lauryl Acrylate Crosspolymer, Lauryl Methacrylate / Glycol Dimethacrylate Crosspolymer, MEA Sulfites, Methacrylic Acid / Sodium Acrylamidomethyl Propane Sulfonate Copolymer, Methacryloyl Ethyl Betaine / Acrylates Copolymer, Octyl Acrylamide / Acrylates / Butylaminoethyl Methacrylate Copolymer, PEG / PPG 25/25

Dimethicone / acrylate copolymer, PEG-8 / SMDI copolymer, polyacrylamide, polyacrylate-6, polybeta-alanine / glutaric acid crosspolymer, polybutylene terephthalate, polyester-1, polyethylacrylate, polyethylene terephthalate, polymethacryloyl ethyl betaine, polypentaerythrityl terephthalate, polyperfluoroperhydrophenanthrenes, polyquaternium-1 , Polyquaternium-2, Polyquaternium-4, Polyquaternium-5, Polyquaternium-6, Polyquaternium-7, Polyquaternium-8, Polyquaternium-9, Polyquaternium-10, Polyquaternium-11, Polyquaternium-12, Polyquaternium-13, Polyquaternium-14, Polyquaternium -15, Polyquaternium-16, Polyquaternium-17, Polyquaternium-18, Polyquaternium-19, Polyquaternium-20, Polyquaternium-22, Polyquaternium-24, Polyquaternium-27, Polyquaternium-28, Polyquaternium-29, Polyquaternium-30, Polyquaternium-31 , Polyquaternium-32, Polyquaternium-33, Polyquaternium-34, Polyquaternium-35, Polyquaternium-36, Polyquaternium-37, Polyquaternium-39, Polyquaternium-45, Polyquaternium-46, Polyquaternium-4 7, Polyquaternium-48, Polyquaternium-49, Polyquaternium-50, Polyquaternium-55, Polyquaternium-56, Polysilicone-9, Polyurethane-1, Polyurethane-6, Polyurethane-10, Polyvinylacetates, Polyvinylbutyral, Polyvinylcaprolactam, Polyvinylformamides, Polyvinylimidazolinium Acetates, Polyvinyl Methyl Ether, Potassium Butyl Ester of PVM / MA Copolymer, Potassium Ethyl Ester of PVM / MA Copolymer, PPG-70 Polyglyceryl-10 Ether, PPG-12 / SMDI Copolymer, PPG-51 / SMDI Copolymer, PPG-10 Sorbitol , PVM / MA Copolymer, PVP, PVP / VA / ltaconic Acid Copolymer, PVP / VA / Vinyl Propionate Copolymer, Rhizobian Gum, Rosin Acrylate, Shellac, Sodium Butyl Ester of PVM / MA Copolymer, Sodium Ethyl Ester of PVM / MA Copolymer, Sodium Polyacrylate, Sterculia Urens Gum, Terephthalic Acid / Isophthalic Acid / Sodium Isophthalic Acid Sulfonate / Glycol Copolymer, Trimethylolpropane Triacrylate, Trimethylsiloxysilylcarbamoyl Pullulan, VA / Crotonates Copolymer, VA / Crotonates / Methacryloxybenzophenone-1 Copolymer, VA / Crotonates® / inyl Neodecano ate Copolymer, VA / Crotonates / Vinyl Propionate Copolymer, VA / DBM Copolymer, VA / Vinyl Butyl Benzoate / Crotonates Copolymer, Vinylamine / Vinyl Alcohol Copolymer, Vinyl Caprolactam / VP / Dimethylaminoethyl Methacrylate Copolymer, VP / Acrylates / Lauryl Methacrylate Copolymer, VP / dimethylaminoethyl methacrylate copolymer, VP / DMAPA acrylate copolymer, VP / Hexadecene Copolymer, VP / VA Copolymer, VP / Vinyl Caprolactam / DMAPA Acrylate Copolymer, Yeast Palmitate.

Preparation (B) of the two-component agent contains at least one conditioner.

The care substance is preferably at least one silicone oil and / or one silicone gum.

Silicone oils or silicone gums which are suitable according to the invention are in particular dialkyl and alkylaryl siloxanes, for example dimethylpolysiloxane and methylphenylpolysiloxane, and also their alkoxylated, quaternized or else anionic derivatives. Preference is given to cyclic and linear polydialkylsiloxanes, their alkoxylated and / or aminated derivatives, dihydroxypoly-dimethylsiloxanes and polyphenylalkylsiloxanes.

Silicone oils cause a wide variety of effects. For example, at the same time they influence the dry and wet combability, the grip of dry and wet hair and the shine. The term silicone oils is understood by the person skilled in the art as meaning several structures of silicon-organic compounds. Initially, these are understood to mean the dimethiconols (S1). These may be both linear and branched as well as cyclic or cyclic and branched. Linear dimethiconols can be represented by the following structural formula (S1-I):

(HOSiR ¹ ₂ ) - O - (SiR ² ₂ - O -) _x - (Si R ¹ ₂ OH) (S1 - I)

Branched dimethiconols can be represented by the structural formula (S1-II):

R ² I

(HOSiR ¹ ₂ ) - O - (SiR ² _Z - O -) _x - Si - O - (SiR ² ₂ - O -) _y - (SiOHR ¹ ₂ )

IO - (SiR ² Z - O -) z - (SiOHR ¹ z)

The radicals R ¹ and R ² are each independently hydrogen, a methyl radical, a C ₂ to C ₃₀ linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical. Non-limiting examples of the groups represented by R ¹ and R ² include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, neopentyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals, such as 3-chloropropyl, 4- Bromobutyl, 3,3,3-trifluoropropyl, chlorocyclohexyl, bromophenyl, chlorophenyl and the like, and sulfur-containing groups such as mercaptoethyl, mercaptopropyl, mercaptohexyl, mercaptophenyl and the like; Preferably R ¹ and R ^{2 is} an alkyl radical containing from 1 to about 6 carbon atoms, most preferably R ¹ and R ^{2 are} methyl. The numbers x, y and z are integers and each run independently from 0 to 50,000. The molecular weights of the dimethiconols are between 1,000 D and 10000000 D. The viscosities are between 100 and 10,000,000 cPs measured at 25 ⁰ C by means of a glass capillary viscometer according to Dow Corning Corporate Test Method CTM 0004 dated 20 July 1970. Preferred viscosities are 1000-5000000 cPs, most preferred viscosities are between 10,000 and 3,000,000 cps. The most preferred range is between 50,000 and 2,000,000 cps.

Examples of such products include the following commercial products: Botanisil NU-150M (Botanigenics), Dow Coming 1-1254 Fluid, Dow Corning 2-9023 Fluid, Dow Corning 2-9026 Fluid, Ultrapure Dimethiconol (Ultra Chemical), Unisil SF- R (Universal Preserve), X-21-5619 (Shin-Etsu Chemical Co.), Abil OSW 5 (Degussa Care Specialties), ACC DL-9430 Emulsion (Taylor Chemical Company), AEC Dimethiconol & Sodium Dodecylbenzenesulfonate (A & E Connock (Perfumery & Cosmetics) Ltd.), BC Dimethiconol Emulsion 95 (Basildon Chemical Company, Ltd.), Cosmetic Fluid 1401, Cosmetic Fluid 1403, Cosmetic Fluid 1501, Cosmetic Fluid 1401 DC (all aforementioned Chemsil Silicones, Inc.), Dow Corning 1401 Fluid, Dow Corning 1403 Fluid, Dow Corning 1501 Fluid, Dow Corning 1784 HVF Emulsion, Dow Corning 9546 Silicone Elastomer Blend (all aforementioned Dow Corning Corporation), Dub Gel Sl 1400 (Stearinerie Dubois FiIs), HVM 4852 Emulsion (Crompton Corporation), Jeesilc 6056 (Jeen Internationa l Corporation), Lubrasil, Lubrasil DS (both Guardian Laboratories), Nonychosine E, Nonychosine V (both exsymol), SanSurf Petrolatum-25, Satin Finish (both Collaborative Laboratories, Inc.), Silatex-D30 (Cosmetic Ingredient Resources), Silsoft 148, Silsoft E-50, Silsoft E-623 (all previously referred to Crompton Corporation), SM555, SM2725, SM2765, SM2785 (all aforementioned GE Silicones), Taylor T-SiI CD-1, Taylor TME-4050E (all Taylor Chemical Company), THV 148 (Crompton Corporation), Tixogel CYD-1429 (Sud-Chemie Performance Additives), Wacker-Belsil CM 1000, Wacker-Belsil CM 3092, Wacker-Belsil CM 5040, Wacker-Belsil DM 3096, Wacker-Belsil DM 3112 VP, Wacker-Belsil DM 8005 VP, Wacker-Belsil DM 60081 VP (all Wacker-Chemie GmbH mentioned above).

Dimethicones (S2) form the second group of silicones which may be present in preparation (B) according to the invention. These may be both linear and branched as well as cyclic or cyclic and branched. Linear dimethicones can be represented by the following structural formula (S2-I):

(SiR ¹ ₃ ) - O - (SiR ¹ R ² - O -) _x - (SiR ¹ ₃ ) (S2 - I) Branched dimethicones can be represented by the structural formula (S2-II):

R ²

I

(SiR ¹ ₃₎ - O - (Si R ¹ R ² - O -) _x - Si - O - (Si R ¹ R ² - O -) _y - (SiR ¹ ₃₎

IO - (Si R ¹ R ² - O -) _z - (SiR ¹ ₃₎

The radicals R ¹ and R ² are each independently hydrogen, a methyl radical, a C ₂ to C ₃₀ linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical. Non-limiting examples of the groups represented by R ¹ and R ² include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, neopentyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-bromobutyl, 3,3,3-trifluoropropyl, chlorocyclohexyl, bromophenyl, chlorophenyl and the like, and sulfur-containing radicals such as mercaptoethyl, mercaptopropyl, mercaptohexyl, mercaptophenyl and the like; Preferably, R ¹ and R ^{2 is} an alkyl radical containing from 1 to about 6 carbon atoms, and more preferably R ¹ and R ^{2 are} methyl. The numbers x, y and z are integers and each run independently from 0 to 50,000. The molecular weights of Dimethicone lie between 1,000 D and 10000000 D. The viscosities are between 100 and 10,000,000 cPs measured at 25 ⁰ C by means of a glass capillary viscometer according to Dow Corning Corporate Test Method CTM 0004 dated 20 July 1970. Preferred viscosities are 1000-5000000 cPs, particularly preferred viscosities are between 10,000 and 3,000,000 cps. Most preferably, the viscosity is in the range between 50,000 and 200,000 cps.

Dimethicone copolyols (S3) form another group of silicones suitable for use in formulation (B). Dimethicone copolyols can be represented by the following structural formulas:

(SiR ¹ ₃ ) - O - (SiR ² Z - O -) χ - (SiR ² PE - O -) _y - (SiR ¹ ₃ ) (S3 - I),

PE - (SiR ¹ ₂ ) - O - (SiR ² ₂ - O -) χ - (SiR ¹ ₂ ) - PE (S3 - II)

Branched dimethicone copolyols can be represented by the structural formula (S3-III): R ²

I PE - (SiR ¹ ₂ ) - O - (SiR ² ₂ - O -) _x - Si - O - (SiR ² ₂ - O -) _y - (SiR ¹ ₂ ) - PE (S3 - III)

IO - (SiR ² ₂ - O -) _z - (SiR ¹ ₂ ) - PE

or by the structural formula (S3 - IV):

R ² I

(SiR ¹ ₃ ) - O - (SiR ² ₂ - O -) _x - Si - O - (SiR ² PE - O -) _y - (SiR ¹ ₃ ) (S3-IV)

IO - (SiR ² ₂ - O -) _z - (SiR ¹ ₃ )

The radicals R ¹ and R ² are each independently hydrogen, a methyl radical, a C ₂ to C ₃₀ linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical. Non-limiting examples of the groups represented by R ¹ and R ² include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, neopentyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-bromobutyl, 3,3,3-trifluoropropyl, chlorocyclohexyl, bromophenyl, chlorophenyl and the like, and sulfur-containing radicals such as mercaptoethyl, mercaptopropyl, mercaptohexyl, mercaptophenyl and the like; Preferably R ¹ and R ^{2 is} an alkyl radical containing from 1 to about 6 carbon atoms, most preferably R ¹ and R ^{2 are} methyl. PE stands for a polyoxyalkylene radical. Preferred polyoxyalkylene radicals are derived from ethylene oxide, propylene oxide and glycerol. The numbers x, y and z are integers and each run independently from 0 to 50,000. The molecular weights of Dimethicone lie between 1,000 D and 10000000 D. The viscosities are between 100 and 10,000,000 cPs measured at 25 ⁰ C by means of a glass capillary viscometer according to Dow Corning Corporate Test Method CTM 0004 dated 20 July 1970. Preferred viscosities are 1000-5000000 cps, most preferred viscosities are between 10,000 and 3,000,000 cps. The most preferred range is between 50,000 and 2,000,000 cps.

Corresponding dimethicone copolyols are commercially available and are sold, for example, by Dow Corning under the name Dow ^Corning® 5330 Fluid. Of course, the teaching according to the invention also encompasses the fact that the dimethiconols, dimethicone and / or dimethicone copolymers can already be present as an emulsion. In this case, the corresponding emulsion of dimethiconols, dimethicones and / or dimethicone copolyols can be prepared both after the preparation of the corresponding dimethiconols, dimethicones and / or dimethicone copolyols from these and the conventional methods of emulsification known to the person skilled in the art. For this purpose, both cationic, anionic, nonionic or zwitterionic surfactants and emulsifiers can be used as auxiliaries for the preparation of the corresponding emulsions. Of course, the emulsions of dimethiconols, dimethicones and / or dimethicone copolyols can also be prepared directly by an emulsion polymerization process. Such methods are also well known to the person skilled in the art. For example, reference may be made to the Encyclopedia of Polymer Science and Engineering, Volume 15, Second Edition, pages 204 to 308, John Wiley & Sons, Inc. 1989. This reference is expressly incorporated herein by reference.

When the dimethiconols, dimethicones and / or dimethicone copolyols according to the invention are used as emulsion, the droplet size of the emulsified particles is according to the invention 0.01 to 10,000 microns, preferably 0.01 to 100 .mu.m, more preferably 0.01 to 20 microns and most preferably 0.01 to 10 μm. The particle size is determined by the method of light scattering.

If branched dimethiconols, dimethicones and / or dimethicone copolyols are used, it is to be understood that the branching is greater than a random branching, which occurs randomly due to impurities of the respective monomers. For the purposes of the present invention, branched dimethiconols, dimethicones and / or dimethicone copolyols are therefore to be understood as meaning that the degree of branching is greater than 0.01%. Preferably, a degree of branching is greater than 0.1%, and most preferably greater than 0.5%. The degree of branching is determined from the ratio of the unbranched monomers to the branching monomers, that is, the amount of tri- and tetrafunctional siloxanes. According to the invention, both low-branched and highly branched dimethiconols, dimethicones and / or dimethicone copolyols can be very particularly preferred.

Suitable silicones are furthermore amino-functional silicones (S4), in particular the silicones which are grouped under the INCI name amodimethicones. These are silicones which have at least one, optionally substituted, amino group.

Such silicones may e.g. by the formula (S4-1)

M (R _a Q _b Si0 _{(4 a b) / 2..))} X (R _c Si0 _{(4 c.) / 2)) y} M (S4 - I) wherein R in the above formula is a hydrocarbon or a hydrocarbon group having from 1 to about 6 carbon atoms, Q is a polar group of the general formula -R ¹ Z wherein R ^{1 is} a divalent linking group attached to hydrogen and Z is an organic, amino-functional radical which contains at least one amino-functional group, and Z is an organic, amino-functional radical which is composed of carbon and hydrogen atoms, carbon, hydrogen and oxygen atoms or carbon, hydrogen and nitrogen atoms; "a" assumes values in the range of about 0 to about 2, "b" assumes values in the range of about 1 to about 3, "a" + "b" is less than or equal to 3, and "c" is a number in the range from about 1 to about 3, and x is a number ranging from 1 to about 2,000, preferably from about 3 to about 50, and most preferably from about 3 to about 25, and y is a number ranging from about 20 to about 10,000 , preferably from about 125 to about 10,000, and most preferably from about 150 to about 1,000, and M is a suitable silicone end group as known in the art, preferably trimethylsiloxy. Non-limiting examples of the groups represented by R include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-bromobutyl, 3,3,3-trifluoropropyl, chlorocyclohexyl, bromophenyl, chlorophenyl and the like, and sulfur-containing radicals such as mercaptoethyl, mercaptopropyl, mercaptohexyl, mercaptophenyl and the like; preferably R is an alkyl radical containing from 1 to about 6 carbon atoms, and most preferably R is methyl. Examples of R ¹ include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH ₂ CH (CI-I ₃ ) CH ₂ -, phenylene, naphthylene, -CH ₂ CH ₂ SCH ₂ CH ₂ -, - CH ₂ CH ₂ OCH ₂ -, -OCH ₂ CH ₂ -, -OCH ₂ CH ₂ CH ₂ -, -CH ₂ CH (CH ₃ ) C (O) OCH ₂ -, - (CH ₂ ) ₃ C (O) OCH ₂ CH ₂ - , - C ₆ H ₄ C ₆ H ₄ -, -C ₆ H ₄ CH ₂ C ₆ H ₄ -; and - (CH ₂ ) ₃ C (O) SCH ₂ CH ₂ -.

Z is an organic, amino-functional radical containing at least one functional amino group. A possible formula for Z is NH (CH ₂ ) _Z NH ₂ , where z is an integer from 1 to 50. Another possible formula for Z is -NH (CH ₂ ) _Z NH (CH ₂ ) _ZZ) in which both z and zz independently of one another represent an integer from 1 to 50, this structure comprising diamino ring structures, such as piperazinyl. Z is particularly preferably a -NHCH ₂ CH ₂ NH ₂ radical. Another possible formula for Z is -N (CH ₂ ) _Z NX ¹ X ² or -NX ¹ X ² , wherein each of X ¹ and X ² is independently selected from hydrogen and a hydrocarbon radical having from 1 to about 6 carbon atoms.

Most preferably, Q is a polar, amine-functional radical of the formula - CH ₂ CH ₂ CH ₂ NHCH ₂ CH ₂ NH ₂ .

The molar ratio of the R _a Q _b SiO _{(4 a a b} ) _{/ 2} units to the R ₀ SiO _{(4 C) 2} units is in the range of about 1: 2 to 1:65, preferably about 1: 5 to about 1:65 and more preferably from about 1:15 to about 1:20. When one or more silicones of the above formula are employed, then the various variable substituents in the above formula may be different for the various silicone components present in the silicone blend.

Preferred amino-functional silicones correspond to the formula (S4 - II)

R ^ G _3-3 -Si (OSiG _{2) n} - (OSiG _b R _{'2-b) m} -O-SiG _3-a -R' _a (S4 - II),

where:

G is -H, a phenyl group, -OH, -O-CH ₃ , -CH ₃ , -CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₃ ,

-CH (CH ₃ ) ₂ , -CH ₂ CH ₂ CH ₂ CH ₃ , -CH ₂ CH (CH ₃ ) ₂ , -CH (CH ₃ ) CH ₂ CH ₃ , -C (CH ₃ ) ₃ ;

a is a number between 0 and 3, in particular 0;

b is a number between 0 and 1, in particular 1,

m and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n is preferably values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10,

- R ^'is a monovalent radical selected from o -N (R ") - CH ₂ -CH ₂ - N (R") ₂ o -N (R ") ₂ o -N ⁺ (R ¹¹ J ₃ ^A" o - N ⁺ H (R ¹¹ J ₂ A ^" o -N ⁺ H ₂ (R ¹¹ JA- O -N (R ¹¹ J-CH ₂ -CH ₂ -N ⁺ R ¹¹ H ₂ A-, where each R" is the same or various radicals from the group -H, -phenyl, -benzyl, the C ^ o-alkyl radicals, preferably -CH ₃ , -CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₃ , -CH (CH ₃ J ₂ , - CH ₂ CH ₂ CH ₂ CH ₃ , -CH ₂ CH (CH ₃ ) ₂ ,

-CH (CH ₃ ) CH ₂ CH ₃ , -C (CH ₃ J ₃ , and A ^'represents an anion which is preferably selected from chloride, bromide, iodide or methosulfate.

Particularly preferred amino-functional silicones correspond to the formula (S4 - III)

(CH ₃ ) ₃ Si - [O-Si (CH ₃ ) ₂ ] _n [OSi (CH ₃ )] _m - OSi (CH ₃ ) ₃ (S 4 - III),

I

CH ₂ CH (CH ₃ ) CH ₂ NH (CH ₂ ) ₂ NH ₂

wherein m and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n is preferably values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10. These silicones are referred to as trimethylsilylamodimethicones according to the INCI declaration.

Particular preference is furthermore given to amino-functional silicones of the formula (S4-IV)

R- [Si (CH _{3) 2} -O] _n1 [Si (R) -O] _m - [Si (CH _{3) 2] n2} -R (S4 - IV),

(CHz) ₃ NH (CHz) ₂ NH ₂

wherein R is -OH, -O-CH ₃ or a -CH ₃ group and m, n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2,000, preferably between 50 and 150, wherein the sum (n1 + n2) preferably assumes values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10.

These silicones are referred to as amodimethicone according to the INCI nomenclature and are for example in the form of an emulsion as a commercial product Dow Corning ^® 949 in a mixture with a cationic and a nonionic surfactant available.

Preferably, those amino-functional silicones are used which have an amine number above 0.25 meq / g, preferably above 0.3 meq / g and especially preferably above 0.4 meq / g. The amine number stands for the milliequivalents of amine per gram of the amino-functional silicone. It can be determined by titration and also expressed in mg KOH / g.

Other suitable silicones are, for example, oligomeric polydimethylcyclosiloxanes (INCI name: cyclomethicone), in particular the tetrameric and the pentameric compound, which are available as commercial products DC 245 fluid, DC

344 or DC 345 are sold by Dow Corning,

Hexamethyl disiloxane (INCI name: Hexamethyldisiloxane), z. B. that under the

Name Abil ^® K 520 marketed product,

Polyphenylmethylsiloxanes (INCI name: phenyl trimethicone), z. B. the

Commercial product DC 556 Cosmetic Grade Fluid from Dow Corning,

Esters and partial esters of silicone-glycol copolymers, such as those of the

Company Fanning under the trade name Fancorsil ^® LIM (INCI name:

Dimethicone Copolyol Meadowfoamate), anionic silicone oils, such as the product Dow ^Coming® 1784.

According to a preferred embodiment, preparation (B) contains at least two different silicone derivatives, more preferably a combination of a volatile one and a nonvolatile silicone. Volatile in the context of the invention are those silicones which have a volatility which is equal to or greater than the volatility of the cyclic, pentameric dimethylsiloxane. Such combinations are also available as commercial products (eg, Dow ^Corning® 1401, Dow ^Corning® 1403, and Dow ^Corning® 1501, each containing mixtures of a cyclomethicone and a dimethiconol).

Preferred mixtures of different silicones are, for example, dimethicones and dimethiconols, linear dimethicones and cyclic dimethiconols. A very particularly preferred mixture of silicones consists of at least one cyclic dimethiconol and / or dimethicone, at least one further non-cyclic dimethicone and / or dimethiconol and at least one amino-functional silicone.

If different silicones are used as a mixture, the mixing ratio is largely variable. However, all the silicones used for mixing are preferably used in a ratio of 5: 1 to 1: 5 in the case of a binary mixture. A ratio of 3: 1 to 1: 3 is particularly preferred. Very particularly preferred mixtures contain all the silicones contained in the mixture largely in a ratio of about 1: 1, in each case based on the amounts used in wt .-%.

The preparations preferably contain the silicones in amounts of from 1 to 25% by weight, more preferably from 5 to 20% by weight and especially preferably from 7 to 15% by weight, based on the total application preparation, ie. based on the sum of preparation (A) and preparation (B).

Although the product according to the invention preferably contains a silicone derivative as care component, it is also possible for preparation (B) to contain at least one care substance of another class of compounds instead of or in addition to a silicone component.

As a care substance of another class of compounds, the preparation (B) of the product according to the invention may contain, for example, at least one cationic surfactant.

Cationic surfactants of the quaternary ammonium compounds, esterquats and amidoamines type are preferred according to the invention. Preferred quaternary ammonium compounds are ammonium halides, in particular chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides, eg. As cetyltrimethylammonium chloride, stearyltrimethylammonium chloride, distearyldimethyl ammonium chloride, lauryldimethylammonium chloride, Lauryldimethylbenzylammoniumchlorid and tricetylmethylammonium chloride, as well as those under the INCI names Quaternium-27 and Quaternium-83 known imidazolium compounds. The long alkyl chains of the above-mentioned surfactants preferably have 10 to 18 carbon atoms.

Esterquats are known substances which contain both at least one ester function and at least one quaternary ammonium group as a structural element. Preferred ester quats are quaternized ester salts of fatty acids with triethanolamine, quaternized ester salts of fatty acids with diethanolalkylamines and quaternized ester salts of fatty acids with 1,2-dihydroxypropyldialkylamines. Such products are marketed under the trade names Stepantex® ^{®, ®} and Dehyquart® Armocare® ^®. The products Armocare ^® VGH-70, a N, N-bis (2-palmitoyloxyethyl) dimethylammonium chloride, as well as Dehyquart ^® F-75, Dehyquart ^® C-4046, Dehyquart ^® L80 and Dehyquart ^® AU-35 are examples of such esterquats.

The alkylamidoamines are usually prepared by amidation of natural or synthetic fatty acids and fatty acid cuts with dialkylaminoamines. An inventively particularly suitable compound from this group is that available under the name Tegoamid ^® S 18 commercially stearamidopropyl dimethylamine.

The cationic surfactants are preferably present in the products according to the invention in amounts of from 0.05 to 10% by weight, based on the total application preparation. Amounts of 0.1 to 5 wt .-% are particularly preferred.

Nurturing polymers are also suitable as a care substance.

A first group of caring polymers are the cationic polymers. Cationic polymers are to be understood as meaning polymers which have a group in the main and / or side chain which may be "temporary" or "permanent" cationic. According to the invention, "permanently cationic" refers to those polymers which have a cationic group, irrespective of the pH of the agent. These are usually polymers containing a quaternary nitrogen atom, for example in the form of an ammonium group. Preferred cationic groups are quaternary ammonium groups. In particular, such polymers in which the quaternary ammonium group over a

have been bonded to a built-up of acrylic acid, methacrylic acid or their derivatives polymer backbone have been found to be particularly suitable. Homopolymers of the general formula (G1-I), R ¹

I

- [CH ₂ -CJ _n X- (G1-I)

I CO-O- (CH ₂ ) _m -N ⁺ R ² R ³ R ⁴

wherein R ¹ = -H or -CH ₃ , R ² , R ³ and R ^{4 are} independently selected from C _1-4 alkyl, alkenyl or hydroxyalkyl groups, m = 1, 2, 3 or 4 , n is a natural number and X ^'is a physiologically acceptable organic or inorganic anion, as well as copolymers consisting essentially of the monomer units listed in formula (G1-I) and nonionic monomer units, are particularly preferred cationic polymers. In the context of these polymers, those are preferred according to the invention for which at least one of the following conditions applies: R ¹ is a methyl group R ² , R ³ and R ⁴ are methyl groups m has the value 2.

Suitable physiologically compatible counterions X- are, for example, halide ions, sulfate ions, phosphate ions, methosulfate ions and organic ions such as lactate, citrate, tartrate and acetate ions. Preference is given to halide ions, in particular chloride.

A particularly suitable homopolymer is, if desired, crosslinked, poly (meth acryloyloxyethyltrimethylammonium chloride) with the INCI name Polyquaternium-37. If desired, the crosslinking can be carried out with the aid of poly olefinically unsaturated compounds, for example divinylbenzene, tetraallyloxyethane, methylenebisacrylamide, diallyl ether, polyallylpolyglyceryl ethers, or allyl ethers of sugars or sugar derivatives such as erythritol, pentaerythritol, arabitol, mannitol, sorbitol, sucrose or glucose. Methylenebisacrylamide is a preferred crosslinking agent.

The homopolymer is preferably used in the form of a non-aqueous polymer dispersion which should not have a polymer content of less than 30% by weight. Such polymer dispersions are available under the names Salcare ^® SC 95 (about 50% polymer content, additional components: mineral oil (INCI name: Mineral Oil) and tridecyl-polyoxypropylene-polyoxyethylene-ether (INCI name: PPG-1 trideceth-6) ) and Salcare ^® SC 96 (about 50% polymer content, additional components: mixture of diesters of propylene glycol with a mixture of caprylic and capric acid (INCI name: propylene glycol Dicaprylate / Dicaprate) and tridecyl polyoxypropylene-polyoxyethylene-ether (INCI Designation: PPG-1-trideceth-6)) are commercially available. Copolymers with monomer units of the formula (G1-I) contain as nonionic monomer units preferably acrylamide, methacrylamide, acrylic acid-Ci. _4- alkyl esters and methacrylic acid-C _1-4 alkyl esters. Among these nonionic monomers, the acrylamide is particularly preferred. These copolymers can also be crosslinked, as described above in the case of the homopolymers. A copolymer preferred according to the invention is the crosslinked acrylamide-methacryloyloxyethyltrimethylammonium chloride copolymer. Such copolymers in which the monomers are present in a weight ratio of about 20:80, commercially available as about 50% non-aqueous polymer dispersion under the name Salcare ^® SC 92nd

Other preferred cationic polymers are, for example, quaternized cellulose derivatives, such as are available under the names of Celquat ^® and Polymer JR ^® commercially. The compounds Celquat ^® H 100, Celquat ^® L 200 and Polymer JR ^® 400 are preferred quaternized cellulose derivatives, cationic alkyl polyglycosides according to DE-PS 44 13 686, cationized honey, for example the commercial product Honeyquat ^® 50, cationic guar derivatives, such as in particular the products sold under the trade names Cosmedia® ^® guar and Jaguar ^® products,

Quaternary group polysiloxanes such as the commercially available products Q2-7224 (manufactured by Dow Corning, a stabilized trimethylsilylamodimethicone), Dow ^Corning® 929 emulsion (containing a hydroxylamino-modified silicone, also referred to as amodimethicones), SM -2059 (manufacturer: General Electric), SLM-55067 (manufacturer: Wacker) and Abil ^® -Quat 3270 and 3272 (manufacturer: Th. Goldschmidt), diquaternary polydimethylsiloxanes, quaternium-80), polymeric dimethyldiallylammonium salts and their copolymers with esters and amides of acrylic acid and methacrylic acid. The under the. Names Merquat ^® 100 products (poly (dimethyldiallylammonium chloride)) and Merquat ^® 550 (dimethyldiallylammonium chloride acrylamide copolymer) are examples of such cationic polymers,

Copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate, such as diethyl sulfate quaternized vinylpyrrolidone-dimethylaminoethyl methacrylate copolymers. Such compounds are sold under the names Gafquat ^® 734 and Gafquat ^® 755 commercially,

Vinylpyrrolidone-vinyl imidazolium copolymers, such as those offered under the names Luviquat ^® FC 370, FC 550, FC 905 and HM 552, quaternized polyvinyl alcohol, and the polymers known under the names Polyquaternium 2, Polyquaternium 17, Polyquaternium 18 and Polyquaternium 27 with quaternary nitrogen atoms in the polymer main chain.

Can be used as cationic polymers (. B. commercial product, Quatrisoft ^® LM 200) under the designations Polyquaternium-24, known polymers. Also usable in the invention are the copolymers of vinylpyrrolidone, such as the commercial products Copolymer 845 (manufactured by ISP), Gaffix ^® VC 713 (manufactured by ISP), Gafquat ^® ASCP 1011, Gafquat ^® HS 110, Luviquat ^® 8155 and Luviquat ^® MS 370 obtainable are.

Further cationic polymers which can be used according to the invention are the so-called "temporary cationic" polymers. These polymers usually contain an amino group which, at certain pH values, is present as quaternary ammonium group and thus cationic. Preferably, for example, are chitosan and its derivatives, such as, for example, under the trade designations Hydagen CMF ^® ₁ Hydagen HCMF ^®, Kytamer ^® PC and Chitolam ^® NB / 101 are freely available commercially.

According to the invention cationic polymers employed are cationic cellulose derivatives and chitosan and its derivatives, in particular the commercial products Polymer ^® JR 400, Hydagen ^® HCMF and Kytamer ^® PC, cationic guar derivatives, cationic honey derivatives, in particular the commercial product Honeyquat ^® 50, cationic Alkylpolyglycodside according to DE-PS 44 13 686 and polymers of the type Polyquaternium-37.

Furthermore, cationized protein hydrolyzates are to be counted among the cationic polymers, wherein the underlying protein hydrolyzate from the animal, for example from collagen, milk or keratin, from the plant, for example from wheat, corn, rice, potatoes, soy or almonds, marine life forms, for example from fish collagen or algae, or biotechnologically derived protein hydrolysates. The protein hydrolyzates on which the cationic derivatives according to the invention are based can be obtained from the corresponding proteins by chemical, in particular alkaline or acid hydrolysis, by enzymatic hydrolysis and / or a combination of both types of hydrolysis. The hydrolysis of proteins usually results in a protein hydrolyzate having a molecular weight distribution of about 100 daltons up to several thousand daltons. Preference is given to those cationic protein hydrolyzates whose underlying protein content has a molecular weight of 100 to 25,000 daltons, preferably 250 to 5000 daltons. Furthermore, cationic protein hydrolyzates are to be understood as meaning quaternized amino acids and mixtures thereof. The quaternization of the protein hydrolyzates or amino acids is often carried out using quaternary ammonium salts such as N, N-dimethyl-N- (n-alkyl) -N- (2-hydroxy-3-chloro-n-propyl) ammonium halides. Furthermore, the cationic protein hydrolysates may also be further derivatized. As typical examples of the cationic protein hydrolysates and derivatives according to the invention, those mentioned under the INCI names in the "International Cosmetic Ingredient Dictionary and Handbook", (seventh edition 1997, The Cosmetic, Toiletry, and Fragrance Association 1101 17 ^th Street, NW, Suite 300 Cocodimonium Hydroxypropyl Hydrolyzed Casein, Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Hair Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Rice Protein, Cocodimonium Hydroxypropyl Hydrolyzed Soy Protein, Cocodimonium Hydroxypropyl Hydrolyzed Wheat Protein, Hydroxypropyl Arginine Lauryl / Myristyl Ether HCl, Hydroxypropyltrimonium Gelatin, Hydroxypropyltrimonium Hydrolyzed Casein, Hydroxypropyltrimonium Hydrolyzed Collagen, Hydroxypropyltrimonium Hydrolyzed Conchiol in Hydroxypropyltrimonium Hydrolyzed Keratin, Hydroxypropyltrimonium Hydrolyzed Rice Bran Protein, Hydroxypropyltrimonium Hydrolyzed Soy Protein, Hydroxypropyl Hydrolyzed Vegetable Protein, Hydroxypropyltrimonium Hydrolyzed Wheat Protein, Hydroxypropyltrimonium Hydrolyzed Wheat Protein / Siloxysilicate, Laurdimonium Hydroxypropyl Hydrolyzed Soy Protein, Laurdimonium Hydroxypropyl Hydrolyzed Wheat Protein, Laurdimonium Hydroxypropyl Hydrolyzed Wheat Protein / Siloxysilicate, Lauryldimony Hydroxypropyl Hydrolyzed Casein, Lauryldimonium Hydroxypropyl Hydrolyzed Keratin, Lauryldimonium Hydroxypropyl Hydrolyzed Soy Protein, Steardimonium Hydroxypropyl Hydrolyzed Casein, Steardimonium Hydroxypropyl Hydrolyzed Collagen, Steardimonium Hydroxypropyl Hydrolyzed Keratin, Steardimonium Hydroxypropyl Hydrolyzed Rice Protein, Steardimonium Hydroxypropyl Hydrolyzed Soy Protein, Steardimonium Hydroxypropyl Hydrolyzed Vegetable Protein, Steardimo Hydroxypropyl Hydrolyzed Wheat Protein, Steartrimonium Hydroxyethyl Hydrolyzed Collagen, Quaternium-76 Hydrolyzed Collagen, Quaternium-79 Hydrolyzed Collagen, Quaternium-79 Hydrolyzed Keratin, Quaternium-79 Hydrolyzed Milk Protein, Quaternium-79 Hydrolyzed Soy Protein, Quaternium-79 Hydrolyzed Wheat Protein.

Very particular preference is given to the cationic protein hydrolysates and derivatives based on plants.

Further care polymers which can be used according to the invention are the amphoteric compounds mentioned in British Offenlegungsschrift 2 104 091, European Offenlegungsschrift 47 714, European Offenlegungsschrift 217 274, European Offenlegungsschrift 283 817 and German Offenlegungsschrift 28 17 369.

Preferably used amphoteric polymers are those polymers which are composed essentially (a) monomers having quaternary ammonium groups of the general formula (II), R ¹ -CH = CR ² -CO-Z- (C _n H _2n ) -N ⁽⁺⁾ R ³ R ⁴ R ⁵ A ^w (II) in the R ¹ and R ² independently of one another represent hydrogen or a methyl group and R ³ , R ⁴ and R ⁵ each independently represent an alkyl group having 1 to 4 carbon atoms, Z an NH group or an oxygen atom, n an integer from 2 to 5 and A is the anion of an organic or inorganic acid, and

(b) monomeric carboxylic acids of the general formula (III), R ⁶ -CH = CR ⁷ -COOH (III) in which R ⁶ and R ⁷ independently of one another represent hydrogen or a methyl group.

These compounds can be used both directly and in salt form, which is obtained by neutralization of the polymers, for example with an alkali metal hydroxide, according to the invention. With regard to the details of the preparation of these polymers is expressly made to the content of German Patent Application 39 29 973 reference. Very particular preference is given to those polymers in which monomers of the type (a) are used in which R ³ , R ⁴ and R ^{5 are} methyl groups, Z is an NH group and A ^{H is} a halide, methoxysulfate or ethoxysulfate ion ; Acrylamidopropyltrimethylammonium chloride is a particularly preferred monomer (a). Acrylic acid is preferably used as monomer (b) for the stated polymers.

The products of the invention contain the nourishing, cationic polymers preferably in an amount of 0.01 to 5 wt .-%, in particular in an amount of 0.1 to 2 wt .-%, each based on the total application preparation.

As a conditioner, the product according to the invention may further contain at least one vitamin, a provitamin, a vitamin precursor and / or one of their derivatives.

According to the invention, such vitamins, pro-vitamins and vitamin precursors are preferred, which are usually assigned to groups A, B, C ₁ E, F and H.

The group of substances called vitamin A includes retinol (vitamin A ₁ ) and 3,4-didehydroretinol (vitamin A ₂ ). The ß-carotene is the provitamin of retinol. As vitamin A component according to the invention, for example, vitamin A acid and its esters, vitamin A aldehyde and vitamin A alcohol and its esters such as the palmitate and the acetate into consideration. The preparations used according to the invention preferably contain the vitamin A component in amounts of 0.05-1% by weight, based on the total application preparation.

The vitamin B group or the vitamin B complex include, among others Vitamin B ₁ (thiamine) Vitamin B ₂ (riboflavin)

Vitamin B ₃ . Under this name, the compounds nicotinic acid and nicotinamide (niacinamide) are often performed. Preferred according to the invention is the nicotinic acid amide, which is preferably contained in the agents according to the invention in amounts of from 0.05 to 1% by weight, based on the total application preparation. Vitamin B ₅ (pantothenic acid, panthenol and pantolactone). Panthenol and / or pantolactone are preferably used in the context of this group. Derivatives of panthenol which can be used according to the invention are, in particular, the esters and ethers of panthenol and also cationically derivatized panthenols. Individual representatives are, for example, the panthenol triacetate, the panthenol monoethyl ether and its monoacetate and also the cationic panthenol derivatives disclosed in WO 92/13829. The said compounds of the vitamin B ₅ type are preferably present in the agents according to the invention in amounts of 0.05-10% by weight, based on the total application preparation. Amounts of 0.1-5 wt .-% are particularly preferred.

Vitamin B ₆ (pyridoxine and pyridoxamine and pyridoxal). The compounds of the vitamin B ₆ type mentioned are preferably contained in the agents according to the invention in amounts of 0.01-5% by weight, based on the total application preparation. Levels of 0.05-1 wt% are particularly preferred.

Vitamin C (ascorbic acid). Vitamin C is used in the compositions according to the invention preferably in amounts of 0.1 to 3 wt .-%, based on the total application preparation. Use in the form of palmitic acid ester, glucosides or phosphates may be preferred. The use in combination with tocopherols may also be preferred.

Vitamin E (tocopherols, especially cc-tocopherol). Tocopherol and its derivatives, which include in particular the esters such as acetate, nicotinate, phosphate and succinate, are preferably present in the compositions according to the invention in amounts of 0.05-1% by weight, based on the total application preparation.

Vitamin F. The term "vitamin F" is usually understood as meaning essential fatty acids, in particular linoleic acid, linolenic acid and arachidonic acid.

Vitamin H. Vitamin H is the compound (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-d] - imidazole-4-valeric acid, for which, however, the trivial name biotin has meanwhile prevailed. Biotin is preferred in the compositions of the invention in amounts of 0.0001 to 1, 0 wt .-%, in particular in amounts of 0.001 to 0.01 wt .-%, each based on the total application preparation included.

The products according to the invention preferably contain vitamins, provitamins and vitamin precursors from groups A, B, C, E and H.

Panthenol, pantolactone, pyridoxine and its derivatives as well as nicotinic acid amide and biotin are particularly preferred.

Very particular preference is given to using D-panthenol as a care substance in combination with at least one of the abovementioned silicone derivatives.

As a conditioner, the products of the invention may further contain at least one plant extract.

Usually these extracts are produced by extraction of the whole plant. However, in individual cases it may also be preferred to prepare the extracts exclusively from flowers and / or leaves of the plant.

With regard to the plant extracts preferred according to the invention, particular reference is made to the extracts listed in the table beginning on page 44 of the 3rd edition of the guideline for the ingredient declaration of cosmetic products, published by the Industrial Association for Personal Care and Detergent e.V. (IKW), Frankfurt.

The extracts of green tea, oak bark, nettle, witch hazel, hops, henna, chamomile, burdock root, horsetail, hawthorn, lime blossom, almond, aloe vera, spruce needle, horse chestnut, sandalwood, juniper, coconut, mango, apricot, lime , Wheat, kiwi, melon, orange, grapefruit, sage, rosemary, birch, mallow, meadowfoam, quenelle, yarrow, thyme, lemon balm, toadstool, coltsfoot, marshmallow, meristem, ginseng and ginger root.

Particularly preferred are the extracts of green tea, oak bark, nettle, witch hazel, hops, chamomile, burdock root, horsetail, lime blossom, almond, aloe vera, coconut, mango, apricot, lime, wheat, kiwi, melon, orange, grapefruit, sage, Rosemary, birch, meadowfoam, quenelle, yarrow, toadstool, meristem, ginseng and ginger root.

Especially suitable are the extracts of green tea, almond, aloe vera, coconut, mango, apricot, lime, wheat, kiwi and melon. As extraction agent for the preparation of said plant extracts water, alcohols and mixtures thereof can be used. Among the alcohols are lower alcohols such as ethanol and isopropanol, but especially polyhydric alcohols such as ethylene glycol and propylene glycol, both as sole extractant and in admixture with water, are preferred. Plant extracts based on water / propylene glycol in a ratio of 1:10 to 10: 1 have proven to be particularly suitable.

The plant extracts can be used according to the invention both in pure and in diluted form. If they are used in diluted form, they usually contain about 2 to 80 wt .-% of active substance and as a solvent used in their extraction agent or extractant mixture.

Furthermore, it may be preferred to use in the compositions according to the invention mixtures of several, especially two, different plant extracts.

As a care substance, a series of carboxylic acids are also suitable.

In the context of the invention, short-chain carboxylic acids may in particular be advantageous. Short-chain carboxylic acids and their derivatives in the context of the invention are understood to mean carboxylic acids which may be saturated or unsaturated and / or straight-chain or branched or cyclic and / or aromatic and / or heterocyclic and have a molecular weight of less than 750. For the purposes of the invention, preference may be given to saturated or unsaturated straight-chain or branched carboxylic acids having a chain length of from 1 to 16 C atoms in the chain, very particular preference being given to those having a chain length of from 1 to 12 C atoms in the chain.

The short-chain carboxylic acids according to the invention may have one, two, three or more carboxy groups. Preferred within the meaning of the invention are carboxylic acids having a plurality of carboxy groups, in particular di- and tricarboxylic acids. The carboxy groups can be wholly or partly present as esters, acid anhydride, lactone, amide, imidic acid, lactarriv lactim, dicarboximide, carbohydrazide, hydrazone, hydroxam, hydroxime, amidine, amidoxime, nitrile, phosphonic or phosphate ester. The carboxylic acids which can be used according to the invention may of course be substituted along the carbon chain or the ring skeleton. The substituents of the carboxylic acids which can be used according to the invention include, for example, C ₁ -C ₅ -alkyl, C ₂ -C ₈ -alkenyl, aryl, aralkyl and aralkenyl, hydroxymethyl, C ₂ -C ₈ -hydroxyalkyl, C ₂ -C _8- hydroxyalkenyl, aminomethyl, C ₂ -C ₈ -aminoalkyl, cyano, formyl, oxo, thioxo, hydroxy, mercapto, amino, carboxy or imino groups. Preferred substituents are C ₁ -C ₈ alkyl, hydroxymethyl, hydroxy, amino and carboxy groups. Particular preference is given to substituents in the α position. Very particularly preferred substituents are hydroxyl, alkoxy and amino groups, wherein the amino function may optionally be further substituted by alkyl, aryl, aralkyl and / or alkenyl radicals. Furthermore, preferred carboxylic acid derivatives are the phosphonic and phosphate esters.

Examples of carboxylic acids which can be used according to the invention include formic acid, acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, pivalic acid, oxalic acid, malonic acid, succinic acid, glutaric acid, glyceric acid, glyoxylic acid, adipic acid, pimelic acid, suberic acid, azelaic acid, sebacic acid, propiolic acid, crotonic acid, isocrotonic acid, elaidic acid, maleic acid, fumaric acid, muconic acid, citraconic acid, mesaconic acid, camphoric acid, benzoic acid, o, m, p-phthalic acid, naphthoic acid, Toluoylsäure, hydratropic acid, atropic acid, cinnamic acid, isonicotinic acid, nicotinic acid, Bicarbaminsäure, 4,4 ^'- dicyano -6.6 ^{'-binicotinsäure,} 8-Carbamoyloctansäure, 1, 2,4-pentanetricarboxylic acid, 2-pyrrolecarboxylic acid, 1, 2,4,6,7-Napthalinpentaessigsäure, malonaldehydic, 4-hydroxy-phthalamic acid, 1-pyrazolecarboxylic acid, gallic acid or Propanetricarboxylic acid, a dicarboxylic acid selected from the group that is formed by compounds of general formula (NI),

(N-I)

in the Z represents a linear or branched alkyl or alkenyl group having 4 to 12 carbon atoms, n is a number from 4 to 12 and one of the two groups X and Y is a COOH group and the other is hydrogen or a methyl or Ethyl radical, dicarboxylic acids of the general formula (NI), which additionally carry 1 to 3 methyl or ethyl substituents on the cyclohexene ring and dicarboxylic acids formed formally from the dicarboxylic acids according to formula (NI) by addition of a molecule of water to the double bond in the cyclohexene ring.

Dicarboxylic acids of the formula (NI) are known in the literature. For example, US Pat. No. 3,753,968 discloses a manufacturing method. The dicarboxylic acids of the formula (NI) can be prepared, for example, by reacting polyunsaturated dicarboxylic acids with unsaturated monocarboxylic acids in the form of a Diels-Alder cyclization. Usually one will assume a polyunsaturated fatty acid as the dicarboxylic acid component. Preferred is the linoleic acid obtainable from natural fats and oils. Acrylic acid, but also, for example, methacrylic acid and crotonic acid are particularly preferred as the monocarboxylic acid component. Normally, in the case of reactions according to Diels-Alder, isomer mixtures in which one component is present in excess are formed. These isomer mixtures can be used according to the invention as well as the pure compounds.

In addition to the preferred dicarboxylic acids according to formula (NI), those dicarboxylic acids which differ from the compounds according to formula (NI) by 1 to 3 methyl or ethyl substituents on the cyclohexyl ring or formally from these compounds by addition of one molecule of water are also usable according to the invention be formed on the double bond of the cyclohexene ring.

The dicarboxylic acid (mixture), which is obtained by reacting linoleic acid with acrylic acid, has proved to be particularly effective according to the invention. It is a mixture of 5- and 6-carboxy-4-hexyl-2-cyclohexene-1-octanoic acid. Such compounds are commercially available under the designations Westvaco Diacid 1550 Westvaco Diacid ^{® ®} 1595 (manufacturer: Westvaco).

In addition to the short-chain carboxylic acids mentioned above by way of example, their physiologically tolerable salts can also be used according to the invention. Examples of such salts are the alkali metal salts, alkaline earth metal salts, zinc salts and ammonium salts, which in the context of the present application also includes the mono-, di- and trimethyl-, -ethyl- and -hydroxyethyl ammonium salts. However, in the context of the invention, neutralized acids can very particularly preferably be used with alkaline-reacting amino acids, such as, for example, arginine, lysine, ornithine and histidine. Furthermore, it may be preferred for formulation reasons to select the carboxylic acid from the water-soluble representatives, in particular the water-soluble salts.

Furthermore, it is inventively preferred to use 2-pyrrolidinone-5-carboxylic acid and derivatives thereof as the carboxylic acid. Particularly preferred are the sodium, potassium, calcium, magnesium or ammonium salts in which the ammonium ion in addition to hydrogen carries one to three C ₁ - to C ₄ alkyl groups. The sodium salt is most preferred. The amounts used in the products according to the invention are preferably from 0.05 to 10% by weight, based on the total application preparation, particularly preferably 0.1 to 5 wt.%, and particularly preferably 0.1 to 3 wt.%.

Furthermore, it is preferred according to the invention to use hydroxycarboxylic acids and here again in particular the dihydroxy, trihydroxy and polyhydroxycarboxylic acids as well as the dihydroxy, trihydroxy and polyhydroxy di-, tri- and polycarboxylic acids. It has been found that, in addition to the hydroxycarboxylic acids, the hydroxycarboxylic acid esters and the mixtures of hydroxycarboxylic acids and their esters as well as polymeric hydroxycarboxylic acids and their esters can be very particularly preferred. Preferred hydroxycarboxylic acid esters are, for example, full esters of glycolic acid, lactic acid, malic acid, tartaric acid or citric acid. Further basically suitable hydroxycarboxylic esters are esters of .beta.-hydroxypropionic acid, tartronic acid, D-gluconic acid, sugar acid, mucic acid or glucuronic acid. Suitable alcohol components of these esters are primary, linear or branched aliphatic alcohols having 8-22 C atoms, ie, for example, fatty alcohols or synthetic fatty alcohols. The esters of Ci ₂ -Ci ₅ fatty alcohols are particularly preferred. Esters of this type are commercially available, eg under the trademark Cosmacol® ^® EniChem, Augusta Industriale. Particularly preferred polyhydroxypolycarboxylic acids are polylactic acid and polyuric acid and their esters.

Furthermore, the products according to the invention may contain at least one protein hydrolyzate and / or one of its derivatives as a care substance.

Protein hydrolysates are product mixtures obtained by acid, alkaline or enzymatically catalyzed degradation of proteins (proteins). According to the invention, the term protein hydrolyzates also means total hydrolyzates as well as individual amino acids and their derivatives as well as mixtures of different amino acids. Furthermore, according to the invention, polymers made up of amino acids and amino acid derivatives are understood by the term protein hydrolyzates. The latter include, for example, polyalanine, polyasparagine, polyserine, etc. Further examples of compounds which can be used according to the invention are L-alanyl-L-proline, polyglycine, glycyl-L-glutamine or D / L-methionine-S-methylsulfonium chloride. Of course, according to the invention, β-amino acids and their derivatives such as β-alanine, anthranilic acid or hippuric acid can also be used. The molecular weight of the protein hydrolysates which can be used according to the invention is between 75, the molecular weight for glycine, and 200,000, preferably the molecular weight is 75 to 50,000 and very particularly preferably 75 to 20,000 daltons.

According to the invention, protein hydrolysates of both vegetable and animal or marine or synthetic origin can be used. Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein protein hydrolysates, which may also be present in the form of salts. Such products are, for example, under the trademarks Dehylan ^® (Cognis), Promois® ^® (Interorgana) Collapuron ^® (Cognis), Nutrilan® ^® (Cognis), Gelita-Sol ^® (German Gelatinefabriken Stoess & Co), Lexein ^® (Inolex) sericin (Pentapharm) and kerasol tm ^® (Croda) sold.

Particularly interesting is the use of silk protein hydrolysates. By silk one understands the fibers of the cocoon of the mulberry silkworm (Bombyx mori L.). The raw silk fiber consists of a double thread fibroin. As a cement substance, sericin holds this double thread together. Silk consists of 70-80% by weight of fibroin, 19-28% by weight of sericin, 0.5-1% by weight of fat and 0.5-1% by weight of dyes and mineral constituents.

The essential components of sericin are with about 46 wt.% Hydroxyamino acids. The sericin consists of a group of 5 to 6 proteins. The essential amino acids of sericin are serine (Ser, 37% by weight), aspartate (Asp, 26% by weight), glycine (Gly, 17% by weight), alanine (Ala), leucine (Leu) and tyrosine (Tyr) ,

The water-insoluble fibroin belongs to the skieroproteins with a long-chain molecular structure. The main components of the fibroin are glycine (44% by weight), alanine (26% by weight), and tyrosine (13% by weight). Another important structural feature of the fibroin is the hexapeptide sequence Ser-Gly-Ala-Gly-Ala-Gly.

Technically, it is possible in a simple manner to separate the two silk proteins from each other. So it is not surprising that both sericin and fibroin are known as raw materials for use in cosmetic products each by itself. Furthermore, protein hydrolysates and derivatives based on the respective individual silk proteins are known raw materials in cosmetic products. For example, sericin as such is available from Pentapharm ltd. sold as a commercial product called Sericin Code 303-02. Far more often, fibroin is offered as a protein hydrolyzate with different molecular weights in the market. These hydrolyzates are sold especially as "silk hydroylates". Thus hydrolyzed fibroin having average molecular weights from 350 to 1000, for example, sold under the trade name Promois ^® Siik. Also in DE 31 39 438 A1 colloidal fibroin solutions are described as an additive in cosmetic products.

The positive properties of the silk protein derivatives of sericin and fibroin are known per se in the literature. Thus, the sales brochure of the company Pentapharm describes the cosmetic effects of sericin on the skin as soothing, hydrating and film-forming. The effect of a fibroin derivative is described for example in DE 31 39 438 A1 described as caring and conditioning for the hair. According to DE 102 40 757 A1, a simultaneous use of sericin and fibroin or their derivatives and / or hydrolyzates also makes it possible to achieve a synergistic increase in the positive effects of the silk proteins and their derivatives.

Therefore, in the product according to the invention as silk protein hydrolyzate, preference is given to an active substance complex (A) consisting of the active substance (A1) selected from sericin, sericin hydrolysates and / or their derivatives, and mixtures thereof, and an active ingredient (A2) selected from fibroin, and / or Fibroinhydrolysaten and / or derivatives thereof and / or mixtures thereof.

The active ingredient complex (A) used according to the invention significantly synergistically improves the above-described essential internal and external structural features and the strength and elasticity of human hair.

As active ingredients (A1) it is possible to use in the active ingredient complex (A): native sericin, hydrolyzed and / or further derivatized sericin, such as commercial products with the INCI names Sericin, Hydrolyzed Sericin, or Hydrolyzed SiIk, a mixture of the amino acids serine, aspartate and glycine and / or their methyl, propyl, iso-propyl, butyl, iso-butyl esters, their salts such as hydrochlorides, sulfates, acetates, citrates, tartrates, wherein in this mixture the serine and / or its derivatives to 20 to 60 wt.%, The aspartate and / or its derivatives to 10 - 40 wt.% And the glycine and / or its derivatives to 5 to 30 wt.% Are included, with the proviso that the amounts of these amino acids and / or their derivatives preferably add up to 100% by weight, and mixtures thereof.

As active ingredients (A2) can be used in the active ingredient complex (A): native, converted into a soluble form fibroin, hydrolyzed and / or further derivatized fibroin, especially partially hydrolyzed fibroin, which contains as its main constituent the amino acid sequence Ser-Gly-Ala-Gly-Ala Gly, the amino acid sequence Ser-Gly-Ala-Gly-Ala-Gly, a mixture of the amino acids glycine, alanine and tyrosine and / or their methyl, propyl, iso-propyl, butyl, iso-butyl esters, their salts such as hydrochlorides, sulfates, acetates, citrates, tartrates, wherein in this mixture, the glycine and / or its derivatives in amounts of 20- 60 wt.%, The alanine and its derivatives in amounts of 10 - 40 wt%, and the tyrosine and its derivatives are contained in amounts of 0 to 25 wt.%, with the The proviso that the amounts of these amino acids and / or derivatives thereof preferably add up to 100 wt.%, And their mixtures.

Particularly good nourishing properties can be achieved if one of the two active ingredient components of the active ingredient complex (A) is used in the native or possibly solubilized form. It is also possible to use a mixture of several active substances (A1) and / or (A2).

It may be preferred that the two active compounds (A1) and (A2) in the ratio of 10:90 to 70:30, in particular 15:85 to 50:50 and very particularly 20:80 to 40:60, based on their respective Contents of active substance in the products of the invention can be used.

The derivatives of sericin and fibroin hydrolysates include both anionic and cationized protein hydrolysates. The protein hydrolyzates of sericin and fibroin and the derivatives prepared therefrom can be obtained from the corresponding proteins by chemical, in particular alkaline or acid hydrolysis, by enzymatic hydrolysis and / or a combination of both types of hydrolysis. The hydrolysis of proteins usually results in a protein hydrolyzate having a molecular weight distribution of about 100 daltons up to several thousand daltons. Preference is given to those protein hydrolysates of sericin and fibroin and / or derivatives thereof, whose underlying protein content has a molecular weight of 100 to 25,000 daltons, preferably 250 to 10,000 daltons. Furthermore, cationic protein hydrolysates of sericin and fibroin also mean quaternized amino acids and mixtures thereof. The quaternization of the protein hydrolysates or amino acids is often performed by means of quaternary ammonium salts such as N ₁ N-dimethyl-N- (n-alkyl) -N- (2-hydroxy-3-chloro-n-propyl) -ammoniumhalogeniden performed.

Furthermore, the cationic protein hydrolysates may also be further derivatized. As typical examples of the cationic protein hydrolysates and derivatives which can be used according to the invention, those mentioned under the INCI names in the "International Cosmetic Ingredient Dictionary and Handbook", (seventh edition 1997, The Cosmetic, Toiletry, and Fragrance Association 1 101 17 ^th Street, NW, Suite 300, Washington, DC 20036-4702) and commercially available products: Cocodimonium Hydroxypropyl Hydrolyzed SiCl, Cocodimonium Hydroxypropyl SiCl Amino Acids, Hydroxyproypltrimonium Hydrolyzed Silica, Lauryldimonium Hydroxypropyl Hydrolyzed Silica, Steardimonium Hydroxypropyl Hydrolyzed Silica, Quaternium 79 Hydrolyzed Silica. As typical examples of the anionic protein hydrolysates and derivatives according to the invention, those mentioned under the INCI names in the "International Cosmetic Ingredient Dictionary and Handbook", (seventh edition 1997, The Cosmetic, Toiletry, and Fragrance Association 1101 17 ^th Street, NW, Suite 300 , Washington, DC 20036-4702) cited above and commercially available products: Potassium Cocoyl Hydrolyzed SiIk, Sodium Lauroyl Hydrolyzed SiIk or Sodium Stearoyl Hydrolyzed SiIk. Finally, as typical examples of the derivatives of sericin and fibroin which can be used according to the invention, mention may be made of the products commercially available under the INCI names: Ethyl Ester of Hydrolyzed SiIk and Hydrolyzed SiIk PG-Propyl Methylsilanediol. Also useful in the present invention, although not necessarily preferred, are the commercially available products having the INCI names Palmitoyl Oligopeptide, Palmitoyl Pentapeptide-3, Palmitoyl Pentapeptide-2, Acetyl Hexapeptide-1, Acetyl Hexapeptide-3, Copper Tripeptide-1, Hexapeptide-1 , Hexapeptide-2, MEA-Hydrolyzed SiIk.

The effect of the active ingredient complex (A) can be further increased by the addition of fatty substances. Fatty substances are to be understood as meaning fatty acids, fatty alcohols, natural and synthetic waxes, which may be in solid form as well as liquid in aqueous dispersion, and natural and synthetic cosmetic oil components.

Preferred according to the invention is the use of protein hydrolysates of plant origin, eg. Soybean, almond, pea, potato and wheat protein hydrolysates. Such products are, for example, under the trademarks Gluadin ^® (Cognis), diamine ^® (Diamalt) ^® (Inolex), Hydrosoy ^® (Croda), hydro Lupine ^® (Croda), hydro Sesame ^® (Croda), Hydro tritium ^® (Croda) and Crotein ^® (Croda) available.

Although the use of the protein hydrolysates is preferred as such, amino acid mixtures otherwise obtained may be used in their place, if appropriate. Also possible is the use of derivatives of protein hydrolysates, for example in the form of their fatty acid condensation products. Such products are sold for example under the names Lamepon ^® (Cognis), Lexein ^® (Inolex), Crolastin ^® (Croda), Crosilk ^® (Croda) or Crotein ^® (Croda).

Of course, the teaching according to the invention encompasses all isomeric forms, such as eis - trans - isomers, diastereomers and chiral isomers.

According to the invention it is also possible to use a mixture of several protein hydrolysates.

The protein hydrolysates are present in the products according to the invention, for example, in concentrations of from 0.01% by weight to 20% by weight, preferably from 0.05% by weight to 15% by weight and most preferably in amounts of 0.05% by weight. % up to 5% by weight, in each case based on the total application preparation. Ectoin or ectoine derivatives, allantoin, taurine and / or bisabolol are also suitable as care substances.

According to the invention, the term "ectoine and ectoine derivatives" means compounds of the formula (IV)

(IVb)

and / or their physiologically acceptable salt and / or an isomeric or stereoisomeric

Understood form, being

R ¹⁰ represents a hydrogen atom, a branched or unbranched C ₁ -C ₄ -alkyl radical or a C ₂ -C ₄ -hydroxyalkyl radical,

R ¹¹ represents a hydrogen atom, a grouping -COOR ¹⁴ or a grouping -

CO (NH) R ¹⁴ , where R ^{14 may be} a hydrogen atom, a C ₁ -C ₄ -alkyl radical, an amino acid radical, a dipeptide or a tripeptide radical,

R ¹² and R ¹³ independently of one another represent a hydrogen atom, a C ₁ -C ₄ -alkyl radical or a hydroxy group, with the proviso that both radicals may not simultaneously be a hydroxy group, and n is an integer from 1 to 3.

Suitable physiologically tolerated salts of the general compounds of the formula (IVa) or (IVb) are, for example, the alkali metal, alkaline earth metal, ammonium, triethylamine or tris (2-hydroxyethyl) amine salts and those which result from the reaction of compounds according to the formula (IVa) or (IVb) with inorganic and organic acids such as hydrochloric acid, phosphoric acid, sulfuric acid, branched or unbranched, substituted or unsubstituted (for example by one or more hydroxy groups) C ₁ - C ₄ - mono- or dicarboxylic acids, aromatic carboxylic acids and sulfonic acids such as acetic acid, citric acid, benzoic acid, maleic acid, fumaric acid, tartaric acid and p-toluenesulfonic acid. Examples of particularly preferred physiologically acceptable salts are the Na, K, Mg and Ca and ammonium salts of the compounds of the formula (IVa) or (IVb), and the salts which are obtained by reacting compounds of the formula (IVa ) or (IVb) with hydrochloric acid, acetic acid, citric acid and benzoic acid. Isomeric or stereoisomeric forms of the compounds of the formula (IVa) or (IVb) are understood according to the invention to mean all occurring optical isomers, diastereomers, racemates, zwitterions, cations or mixtures thereof.

By the term amino acid, the stereoisomeric forms, e.g. D and L forms, the following compounds understood:

Asparagine, arginine, aspartic acid, glutamine, glutamic acid, β-alanine, γ-aminobutyrate, N _ε -acetyllysine, N _δ -acetylornitine, N _γ -acetyldiaminobutyrate, N _α -acetyldiaminobutyrate, histidine, isoleucine, leucine, methionine, phenylalanine, serine, Threonine and tyrosine.

L-amino acids are preferred. Amino acid residues are derived from the corresponding amino acids. The following amino acid residues are preferred:

Gly, Ala, Ser, Thr, VaI ₁ β-Ala, γ-aminobutyrate, Asp, Glu, Asn, AIn, N _ε -acetyllysine, N _δ -acetylornithine, N _γ -acetyldiaminobutyrate, N _α -acetyldiaminobutyrate.

The short notation of the amino acids was carried out according to the usual notation. The di- or tripeptide radicals are acid amides in their chemical nature and decompose on hydrolysis in 2 or 3 amino acids. The amino acids in the di- or tripeptide moiety are linked together by amide bonds.

With regard to the preparation of the di- and tripeptide radicals, reference is expressly made to EP 0 671 161 A1 of Marbert. Examples of di- and tripeptide radicals can also be found in the disclosure of EP 0 671 161 A1.

Examples of C ₁ -C _t -alkyl groups in the compounds of the formula (IV) are methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl and tert-butyl. Preferred alkyl groups are methyl and ethyl, methyl is a particularly preferred alkyl group. Preferred C ₂ -C ₄ -hydroxyalkyl groups are the groups 2-hydroxyethyl, 3-hydroxypropyl or 4-hydroxybutyl; 2-hydroxyethyl is a particularly preferred hydroxyalkyl group.

The products of the invention contain these care substances preferably in amounts of 0.001 to 2, in particular from 0.01 to 0.5 wt .-%, each based on the total application preparation.

Mono- or oligosaccharides can also be used as a care substance in the products according to the invention.

Both monosaccharides and oligosaccharides, such as, for example, cane sugar, lactose and raffinose, can be used. The use of monosaccharides is preferred according to the invention. Among the monosaccharides, in turn, those compounds which contain 5 or 6 carbon atoms are preferred.

Suitable pentoses and hexoses are, for example, ribose, arabinose, xylose, lyxose, allose, altrose, glucose, mannose, gulose, idose, galactose, talose, fucose and fructose. Arabinose, glucose, galactose and fructose are preferably used carbohydrates; Very particular preference is given to using glucose which is suitable both in the D - (+) or L - (-) configuration or as a racemate.

Furthermore, derivatives of these pentoses and hexoses, such as the corresponding on- and uronic acids (sugar acids), sugar alcohols and glycosides, can also be used according to the invention. Preferred sugars are gluconic acid, glucuronic acid, sugar acid, mannose and mucic acid. Preferred sugar alcohols are sorbitol, mannitol and dulcitol. Preferred glycosides are the methylglucosides.

Since the monosaccharides or oligosaccharides used are usually obtained from natural raw materials such as starch, they usually have the configurations corresponding to these raw materials (for example D-glucose, D-fructose and D-galactose).

The mono- or oligosaccharides are contained in the hair treatment compositions according to the invention preferably in an amount of 0.1 to 8 wt .-%, particularly preferably 1 to 5 wt .-%, based on the total application preparation.

Formulation (B) may further contain at least one lipid as a conditioner.

Lipids suitable according to the invention are phospholipids, for example soya lecithin, egg lecithin and cephalins, and also the substances known under the INCI names linoleic amidopropyl PG-dimonium chlorides phosphates, cocamidopropyl PG-dimonium chlorides phosphates and stearamidopropyl PG-dimonium chlorides phosphates. These are sold, for example, by the company Mona under the trade names Phospholipid ^EFA® , Phospholipid ^PTC® and Phospholipid ^SV® .

The products according to the invention preferably contain the lipids in amounts of from 0.01 to 10% by weight, in particular from 0.1 to 5% by weight, based on the total application preparation.

Furthermore, oil bodies are suitable as a care substance.

The natural and synthetic cosmetic oil bodies include, for example: vegetable oils. Examples of such oils are sunflower oil, olive oil, soybean oil, rapeseed oil, almond oil, jojoba oil, orange oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil. Also suitable, however, are other triglyceride oils such as the liquid portions of beef tallow as well as synthetic triglyceride oils. liquid paraffin oils, isoparaffin oils and synthetic hydrocarbons and di-n-alkyl ethers having a total of from 12 to 36 carbon atoms, in particular 12 to 24 carbon atoms, such as di-n-octyl ether, di-n-decyl ether, di-n-nonyl ether Di-n-undecyl ether, di-n-dodecyl ether, n-hexyl n-octyl ether, n-octyl n-decyl ether, n-decyl n-undecyl ether, n-undecyl n-dodecyl ether and n-hexyl-n Undecyl ether and di-tert-butyl ether, di-iso-pentyl ether, di-3-ethyldecyl ether, tert-butyl-n-octyl ether, iso-pentyl-n-octyl ether and 2-methyl-pentyl-n-octyl ether. The compounds are available as commercial products 1, 3-di- (2-ethyl-hexyl) - cyclohexane (Cetiol ^® S), and di-n-octyl ether (Cetiol ^® OE) may be preferred. Esteröle. Ester oils are to be understood as meaning the esters of C ₆ - C ₃₀ fatty acids with C ₂ - C ₃₀ fatty alcohols. The monoesters of the fatty acids with alcohols having 2 to 24 carbon atoms are preferred. Examples of fatty acid components used in the esters are caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitoleic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linolenic Behenic acid and erucic acid and their technical mixtures which are obtained, for example, in the pressure splitting of natural fats and oils, in the oxidation of aldehydes from Roelen's oxosynthesis or the dimerization of unsaturated fatty acids. Examples of the fatty alcohol components in the ester oils are isopropyl alcohol, caproic alcohol, capryl alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol, arachyl alcohol, Gadoleyl alcohol, behenyl alcohol, erucyl alcohol and brassidyl alcohol and their technical mixtures, for example, in the high-pressure hydrogenation of technical methyl esters based on fats and oils or aldehydes from the Roelen oxo synthesis and as a monomer fraction in the dimerization of unsaturated fatty alcohols incurred. According to the invention particularly preferably isopropyl myristate (IPM Rilanit ^®), isononanoic acid C16-18 alkyl ester (Cetiol ^® SN), 2-ethylhexyl palmitate (Cegesoft ^® 24), stearic acid-2-ethylhexyl ester (Cetiol ^® 868), cetyl oleate, glycerol tricaprylate, Kokosfettalkohol- caprate / caprylate (Cetiol ^® LC), n-butyl stearate, oleyl erucate (Cetiol ^® J 600), isopropyl palmitate (IPP Rilanit ^®), oleyl Oleate (Cetiol ^®), hexyl laurate (Cetiol ^® A), di-n-butyl adipate (Cetiol ^® B), myristyl myristate (Cetiol ^® MM), cetearyl isononanoate (Cetiol ^® SN), oleic acid decyl ester (Cetiol ^® V).

Dicarboxylic acid esters such as di-n-butyl adipate, di- (2-ethylhexyl) adipate, di- (2-ethylhexyl) succinate and di-isotridecyl acelaat, and diol esters such as ethylene glycol dioleate, ethylene glycol di- isotridecanoate, propylene glycol di (2-ethylhexanoate), propylene glycol diisostearate,

Propylene glycol di-pelargonat, butanediol di-isostearate, Neopentylglykoldicaprylat, symmetrical, asymmetric or cyclic esters of carbonic acid with fatty alcohols, for example described in DE-OS 197 56 454, glycerol carbonate or dicaprylyl carbonate (Cetiol ^® CC),

Trifatty acid esters of saturated and / or unsaturated linear and / or branched fatty acids with glycerol,

Fatty acid partial glycerides, which are understood to mean monoglycerides, diglycerides and their technical mixtures. With the use of technical products production reasons may still contain small amounts of triglycerides. The partial glycerides preferably follow the formula (D4-I),

CH ₂ O (CH ₂ CH ₂ O) _1n R ¹ CHO (CH ₂ CH ₂ O) _n R ² (D4-I)

CH ₂ O (CH ₂ CH ₂ O) _q R ³ in the R ¹ , R ² and R ^{3 is} independently of one another hydrogen or a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22, preferably 12 to 18, Carbon atoms are provided with the proviso that at least one of these groups is an acyl radical and at least one of these groups is hydrogen. The sum (m + n + q) is O or numbers from 1 to 100, preferably O or 5 to 25. Preferably, R ^{1 is} an acyl radical and R ² and R ^{3 are} hydrogen and the sum (m + n + q) is O. Typical examples are mono- and / or diglycerides based on caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linolenic , Elaeostearic acid, arachidic acid, gadoleic acid, behenic acid and erucic acid and their technical mixtures. Preferably, oleic acid monoglycerides are used.

The amount used of the natural and synthetic cosmetic oil bodies in the products according to the invention is usually 0.1 to 30% by weight, based on the total application preparation, preferably 0.1 to 20% by weight, and in particular 0.1 to 15% by weight. %.

Moreover, preparation (B) may contain an enzyme as a conditioner. Particularly preferred enzymes according to the invention are selected from a group which is formed from proteases, lipases, transglutaminase, oxidases and peroxidases.

Pearl extracts are also suitable as a conditioner. Pearls of mussels consist essentially of inorganic and organic calcium salts, trace elements and proteins. Pearls can be easily obtained from cultivated mussels. The cultivation of the mussels can be done in fresh water as well as in sea water. This can affect the ingredients of the beads. According to the invention, preference is given to a pearl extract which originates from shells cultivated in marine or salt water. The pearls consist to a large extent of aragonite (calcium carbonate), conchiolin and an albuminoid. The latter components are proteins. Also included in beads are magnesium and sodium salts, inorganic silicon compounds, and phosphates.

To prepare the pearl extract, the beads are pulverized. Thereafter, the pulverized beads are extracted by the usual methods. As extraction agent for the preparation of the pearl extracts, water, alcohols and mixtures thereof can be used. Underwater are understood to mean both demineralized water and seawater. Among the alcohols are lower alcohols such as ethanol and isopropanol, but especially polyhydric alcohols such as glycerol, diglycerol, triglycerol, polyglycerol, ethylene glycol, propylene glycol and butylene glycol, both as sole extractant and in admixture with demineralized water or sea water, are preferred. Pearl extracts based on water / glycerine mixtures have proven to be particularly suitable. Depending on the extraction conditions, the pearl proteins (conchiloin and albuminoid) can be largely in the native state or already partially or largely present as protein hydrolysates. Preference is given to a pearl extract in which conchiolin and albuminoid are already partially hydrolyzed. The essential amino acids of these proteins are glutamic acid, serine, alanine, glycine, aspartic acid and phenylalanine. In a further particularly preferred embodiment, it may be advantageous if the pearl extract is additionally enriched with at least one or more of these amino acids. In the most preferred embodiment, the pearl extract is enriched with glutamic acid, serine and leucine. Furthermore, depending on the extraction conditions, in particular depending on the choice of extractant, a more or less large proportion of minerals and trace elements in the extract is found again. A preferred extract contains organic and / or inorganic calcium salts as well as magnesium and sodium salts, inorganic silicon compounds and / or phosphates. A most preferred pearl extract contains at least 75%, preferably 85%, more preferably 90% and most preferably 95% of all ingredients of the naturally occurring pearls. Examples of pearl extracts usable according to the invention are the commercial products Pearl Protein Extract BG ^® or Crodarom ^® Pearl.

The above-described pearl extracts are preferably contained in an amount of at least 0.01 to 20% by weight. Preference is given to amounts of the extract of from 0.01 to 10% by weight, most preferably used amounts of 0.01 to 5 wt.% Based on the total two-component agent.

Although each of the care substances mentioned in the various embodiments alone already gives a satisfactory result, in the context of the present invention, all embodiments are also included, in which the preparation (B) contains several care substances also from different groups.

Particularly good results in structuring and emphasizing curly hair can be achieved if preparation (B) contains at least two different silicone derivatives and additionally D-panthenol as a care substance. On the one hand, this special combination of special care substances has an intensive care effect and, on the other hand, does not reduce the firming effect of the film-forming polymer. Preparation (B) therefore particularly preferably contains the named combination of care substances.

Both preparation (A) and preparation (B) of the product according to the invention are preferably compounded in an aqueous, an alcoholic or in an aqueous-alcoholic medium, preferably with at least 10% by weight of water, based on the entire preparation. As alcohols, it is possible in particular to include the lower alcohols having 1 to 4 carbon atoms usually used for cosmetic purposes, such as, for example, ethanol and isopropanol. The preparation can be carried out for example in the form of creams, emulsions, gels or surfactant-containing foaming solutions or other preparations which are suitable for use on the hair. The preparations preferably have a pH of from 2 to 11. The pH range between 2 and 8 is particularly preferred. The pH value in the context of this document refers to the pH at 25 ° C., unless otherwise stated.

As additional co-solvents, organic solvents or a mixture of solvents with a boiling point below 400 ⁰ C in an amount of 0.1 to 15 weight percent can preferably from 1 to 10 weight percent based on the total preparation be included. Particularly suitable as additional co-solvents are unbranched or branched hydrocarbons such as pentane, hexane, isopentane and cyclic hydrocarbons such as cyclopentane and cyclohexane. Further, particularly preferred water-soluble solvents are glycerol, ethylene glycol and propylene glycol in an amount of up to 30 percent by weight based on the total preparation.

By adding a UV filter, both the preparations themselves and the treated fibers can be protected from the harmful effects of UV radiation. Preferably, therefore, at least one UV filter is added to preparation (A) and / or (B). The suitable UV filters are not subject to any general restrictions with regard to their structure and their physical properties. On the contrary, all UV filters which can be used in the cosmetics sector and whose absorption maximum is in the UVA (315-400 nm), in the UVB (280-315 nm) or in the UVC (<280 nm) range are suitable. UV filters with an absorption maximum in the UVB range, in particular in the range from about 280 to about 300 nm, are particularly preferred.

The UV filters preferred according to the invention can be selected, for example, from substituted benzophenones, p-aminobenzoic acid esters, diphenylacrylic acid esters, cinnamic acid esters, salicylic acid esters, benzimidazoles and o-aminobenzoic acid esters.

Examples of usable in the invention UV filters are 4-amino-benzoic acid, N ₁ N ₁ N-trimethyl-4- (2-oxoborn-3-ylidenemethyl) aniline methyl sulfate, 3,3,5-trimethyl-cyclohexyl salicylate (Homosalate), 2-hydroxy-4-methoxy-benzophenone (benzophenone-3; Uvinul ^® M 40, Uvasorb MET ^{®, ®} Neo Heliopan BB, Eusolex ^® 4360), 2-phenylbenzimidazole-5-sulfonic acid and potassium, sodium and triethanolamine salts ( Phenylbenzimidazole Sulfonic Acid; Parsol ^® HS; Neo Heliopan Hydro ^®), 3,3 ^ 1, 4-phenylenedimethylene) bis (7,7-dimethyl-2-oxo-bicyclo [2.2.1] hept-1-yl methane-sulfonic acid) and salts thereof, 1- (4-tert-butylphenyl) -3- (4-methoxyphenyl) propane-1, 3- dione (butyl methoxydibenzoylmethane; Parsol ^® 1789 Eusolex ^® 9020), α- ( 2-Oxobom-3-ylidene) - toluene-4-sulfonic acid and salts thereof, ethoxylated 4-aminobenzoic acid ethyl ester (PEG-25 PABA; Uvinul ^® P 25), 4-dimethylaminobenzoic acid 2-ethylhexyl (octyl dimethyl PABA; Uvasorb ^® DMO, Escalol ^® 507, Eusolex ^® 6007), salicylic acid-2-e thylhexyl ester (octyl salicylate; Escalol ^® 587, Neo Heliopan OS ^®, Uvinul ^® O18), 4-methoxycinnamic acid isopentyl (isoamyl p-methoxycinnamate; Neo Heliopan E 1000 ^®), 4-methoxycinnamic acid 2-ethylhexyl ester (Octyl Methoxycinnamate; Parsol ^® MCX, Escalol ^® 557, Neo Heliopan AV ^®), 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and its sodium salt (benzophenone-4; Uvinul ^® MS 40; Uvasorb S 5 ^®), 3- (4'-methylbenzylidene) - D, L-camphor (4-methylbenzylidene camphor; Parsol ^® 5000, Eusolex ^® 6300), 3-benzylidene camphor (3-benzylidene camphor), 4-isopropylbenzyl, 2,4,6-trianilino- (p-carbo-2 '-ethylhexyl-1'-oxi) -1, 3,5-triazine, 3-imidazol-4-yl-acrylic acid and its ethyl ester, polymers of N - {(2 and 4) - [2-oxoborn-3-ylidenemethyl ] benzyl} -acrylamids, 2,4-dihydroxyacetone droxybenzophenon (Benzophenone-1; Uvasorb ^® 20 H ₁ Uvinul ^® 400) 1, 1 '-Diphenylacrylonitrilsäure- 2-ethylhexyl ester (Octocrylene; Eusolex ^® OCR, Neo Heliopan ^® Type 303, Uvinul ^® N 539 SG), o- aminobenzoic acid menthyl ester (menthyl Anthrani late; Neo Heliopan MA ^®), 2,2 ', 4,4'-tetrahydropyran droxybenzophenon (benzophenone-2; Uvinul ^® D-50), 2,2'-dihydroxy-4,4'-dimethoxybenzophenone, 2,2'-dihydroxy-4,4'-dimethoxybenzophenone-5-sodium sulfonate, 6 Benzophenone-) (and 2-cyano-3, 3-diphenylacrylate 2'-ethylhexyl acrylate. Preference is given to 4-aminobenzoic acid, N ₁ N ₁ N-trimethyl-4- (2-oxoborn-3-ylidenemethyl) aniline methylsulfate, SAS-trimethylcyclohexylsalicylate, 2-hydroxy-4-methoxybenzophenone, 2-phenylbenzimidazole 5-sulfonic acid and its potassium, sodium and triethanolamine salts, 3,3 '- (1, 4-phenylenedimethylene) -bis (7,7-dimethyl-2-oxo-bicyclo [2.2.1] hept-1 yl-methanesulphonic acid) and its salts, 1- (4-tert-butylphenyl) -3- (4-methylphenyl) thoxyphenyl) -propane-1, 3-dione, α- (2-oxoborn-3-ylidene) -toluene-4-sulfonic acid and its salts, ethoxylated 4-aminobenzoic acid ethyl ester, 4-dimethylaminobenzoic acid 2-ethylhexyl ester, salicylic acid-2 ethylhexyl ester, isopentyl 4-methoxycinnamate, 2-ethylhexyl 4-methoxycinnamate, 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and its sodium salt, 3- (4'-methylbenzylidene) -D, L-camphor, 3 Benzylidene-camphor, 4-isopropylbenzylsalicylate, 2,4,6-tri- anilino- (p-carbo-2'-ethylhexyl-1'-oxy) -1,3,5-triazine, 3-imidazol-4-yl -acrylic acid and its ethyl ester, polymers of N - {(2 and 4) - [2-oxoborn-3-ylidenemethyl] benzyl} -acrylamide. Very particularly preferred according to the invention are 2-hydroxy-4-methoxybenzophenone, 2-phenylbenzimidazole-5-sulfonic acid and its potassium, sodium and triethanolamine salts, 1- (4-tert-butylphenyl) -3- (4-methoxyphenyl) -propane-1,3-dione, 4-methoxycinnamic acid 2-ethylhexyl ester and 3- (4'-methylbenzylidene) -D, L-camphor.

Preference is given to those UV filters whose molar extinction coefficient at the absorption maximum is above 15,000, in particular above 20,000.

Furthermore, it has been found that structurally similar UV filters in many cases, the water-insoluble compound in the teaching of the invention has the higher effect compared to such water-soluble compounds that differ from it by one or more additional ionic groups. For the purposes of the invention, water-insoluble UV filters are those which dissolve in water at not more than 1% by weight, in particular not more than 0.1% by weight, at 20 ^° C. Furthermore, these compounds should be soluble in the usual cosmetic oil components at room temperature to at least 0.1, in particular at least 1 wt .-%. The use of water-insoluble UV filters may therefore be preferred according to the invention.

According to a further embodiment of the invention, preference is given to those UV filters which have a cationic group, in particular a quaternary ammonium group.

These UV filters have the general structure U - Q.

The structural part U stands for a UV-absorbing group. This group can in principle be derived from the known UV filters which can be used in the cosmetics sector, in which a group, generally a hydrogen atom, of the UV filter is replaced by a cationic group Q _1, in particular having a quaternary amino function becomes.

Compounds from which the structural part U can be derived are, for example, substituted benzophenones, p-aminobenzoic acid esters, Diphenylacrylic esters, cinnamic acid esters, salicylic acid esters, benzimidazoles and o-aminobenzoic acid esters.

Structural parts U which are derived from cinnamic acid amide or from N, N-dimethylaminobenzoic acid amide are preferred according to the invention.

The structural parts U can in principle be chosen such that the absorption maximum of the UV filters can be in both the UVA (315-400 nm) and in the UVB (280-315 nm) or in the UVC (<280 nm) range. UV filters with an absorption maximum in the UVB range, in particular in the range from about 280 to about 300 nm, are particularly preferred.

Furthermore, the structural part U, also as a function of structural part Q, is preferably selected so that the molar extinction coefficient of the UV filter at the absorption maximum is above 15,000, in particular above 20,000.

The structural part Q preferably contains, as a cationic group, a quaternary ammonium group. This quaternary ammonium group can in principle be connected directly to the structural part U, so that the structural part U represents one of the four substituents of the positively charged nitrogen atom. Preferably, however, one of the four substituents on the positively charged nitrogen atom is a group, especially an alkylene group of 2 to 6 carbon atoms, which functions as a compound between the structural portion U and the positively charged nitrogen atom.

Advantageously, the group Q has the general structure - (CH ₂ ) _X -N ⁺ R ¹ R ² R ³ X ^' , in which x is an integer from 1 to 4, R ¹ and R ² independently of one another are C 1 Alkyl groups, R ³ is a C _1-22 alkyl group or a benzyl group and X ^'is a physiologically acceptable anion. In the context of this general structure, x preferably represents the number 3, R ¹ and R ² each represent a methyl group and R ^{3 represents} either a methyl group or a saturated or unsaturated, linear or branched hydrocarbon chain having 8 to 22, in particular 10 to 18, carbon atoms ,

Physiologically acceptable anions are, for example, inorganic anions such as halides, in particular chloride, bromide and fluoride, sulfate ions and phosphate ions and organic anions such as lactate, citrate, acetate, tartrate, methosulfate and tosylate. Two preferred UV filters with cationic groups are the commercially available compounds cinnamic acid-trimethylammonium chloride (lncroquat ^® UV-283) and dodecyl tosylate (Escalol ^® HP 610).

Of course, the teaching of the invention also includes the use of a combination of several UV filters. In the context of this embodiment, the combination of at least one water-insoluble UV filter with at least one UV filter with a cationic group is preferred.

The UV filters are usually contained in amounts of 0.01-5 wt .-%, based on the total application preparation. Amounts of 0.1-2.5 wt .-% are preferred.

In a particular embodiment of the product according to the invention, preparation (A) and / or preparation (B) furthermore contain one or more substantive dyes. This allows the treated keratin fiber not only to be temporarily patterned when the agent is applied, but also dyed at the same time. This may be particularly desirable if only a temporary dyeing is desired, for example, with eye-catching fashion colors, which can be removed again by simple washing from the keratinic fiber.

Direct dyes are usually nitrophenylenediamines, nitroaminophenols, azo dyes, anthraquinones or indophenols. Preferred substantive dyes are those having the international designations or trade names HC Yellow 2, HC Yellow 4, HC Yellow 5, HC Yellow 6, HC Yellow 12, Acid Yellow 1, Acid Yellow 10, Acid Yellow 23, Acid Yellow 36, HC Orange Disperse Orange 3, Acid Orange 7, HC Red 1, HC Red 3, HC Red 10, HC Red 11, HC Red 13, Acid Red 33, Acid Red 52, HC Red BN, Pigment Red 57: 1, HC Blue 2, HC Blue 11, HC Blue 12, Disperse Blue 3, Acid Blue 7, Acid Green 50, HC Violet 1, Disperse Violet 1, Disperse Violet 4, Acid Violet 43, Disperse Black 9, Acid Black 1, and Acid Black 52 known compounds as well as 1,4-diamino-2-nitrobenzene, 2-amino-4-nitrophenol, 1,4-bis- (β-hydroxyethyl) -amino-2-nitrobenzene, 3-nitro-4- (β-hydroxyethyl) -aminophenol, 2- (2'-hydroxyethyl) amino-4,6-dinitrophenol, 1- (2'-hydroxyethyl) amino-4-methyl-2-nitrobenzene, 1-amino-4- (2'-hydroxyethyl) - amino-5-chloro-2-nitrobenzene, 4-amino-3-nitrophenol, 1- (2'-ureidoethyl) amino-4-nitrobenzene, A-amino-2-nitrodiphene ylamin-2'-carboxylic acid, 6-nitro-1,2,3,4-tetrahydroquinoxaline, 2-hydroxy-1, 4-naphthoquinone, picramic acid and its salts, 2-amino-6-chloro-4-nitrophenol, 4- Ethylamino-3-nitrobenzoic acid and 2-chloro-6-ethylamino-1-hydroxy-4-nitrobenzene.

Preference is given to using cationic substantive dyes. Particularly preferred are

(a) cationic triphenylmethane dyes such as Basic Blue 7, Basic

Blue 26, Basic Violet 2 and Basic Violet 14, (b) aromatic systems substituted with a quaternary nitrogen group, such as Basic Yellow 57, Basic Red 76, Basic Blue 99, Basic Brown 16 and Basic Brown 17, as well as

(C) substantive dyes containing a heterocycle having at least one quaternary nitrogen atom, as mentioned for example in EP-A2-998 908, to which reference is explicitly made at this point in claims 6 to 11 are called.

Preferred cationic substantive dyes of group (c) are in particular the following compounds:

CH ₃ SO ₄ ^"

Cf

The compounds of the formulas (DZ1), (DZ3) and (DZ5), which are also known by the names Basic Yellow 87, Basic Orange 31 and Basic Red 51, are very particularly preferred cationic substantive dyes of group (c). The cationic direct dyes, which are sold under the trademark Arianor ^® are, according to the invention also very particularly preferred cationic direct dyes.

The products according to the invention according to this embodiment contain the substantive dyes preferably in an amount of 0.01 to 20 wt .-%, based on the total two-component agent.

Furthermore, the products according to the invention may also contain naturally occurring dyes such as red, henna neutral, henna black, chamomile flower, sandalwood, black tea, buckthorn bark, sage, sawnwood, madder root, catechu, sedre and alkano root.

It is not necessary that the substantive dyes each represent uniform compounds. On the contrary, in the two-component agents according to the invention, due to the production processes for the individual dyes, minor amounts may contain further components, as far as these do not adversely affect the styling result or are of other reasons, e.g. toxicological, must be excluded.

With regard to the dyes which can be used in the products according to the invention, reference is expressly made to the monograph Ch. Zviak, The Science of Hair Care, Chapter 7 (pages 248-250, direct dyes) and Chapter 8, pages 264-267; Oxidation dye precursors), published as Volume 7 of the series "Dermatology" (Editor: Ch., Culnan and H. Maibach), published by Marcel Dekker Inc., New York, Basel, 1986, as well as the "European Inventory of Cosmetic Raw Materials", Issued by the European Community, available in disk form from the Federal Association of German industrial and commercial enterprises for pharmaceuticals, health products and personal care registered association, Mannheim, reference is made.

The preparations (A) and (B) may contain, in addition to the components mentioned, all active substances, additives and auxiliaries known for such preparations.

In many cases, the two-component agents contain at least one surfactant, wherein in principle both anionic and zwitterionic, ampholytic, nonionic and cationic surfactants are suitable. In many cases, however, it has proved to be advantageous to select the surfactants from anionic, zwitterionic or nonionic surfactants.

Furthermore, the two-component agents according to the invention can contain further active ingredients, auxiliaries and additives, such as zwitterionic and amphoteric polymers such as, for example, acrylamidopropyltrimethylammonium chloride / acrylate copolymers and octylacrylamide / methyl methacrylate / tert-butylaminoethyl methacrylate / Z-hydroxypropyl methacrylate copolymers, anionic polymers such as polyacrylic acids, crosslinked polyacrylic acids, vinyl acetate / crotonic acid copolymers, vinylpyrrolidone / vinyl acrylate copolymers,

Vinyl acetate / butyl maleate / isobornyl acrylate copolymers, methyl vinyl ether / maleic anhydride copolymers and acrylic acid / ethyl acrylate / N-tert-butyl acrylamide terpolymers, thickeners such as agar-agar, guar gum, alginates, xanthan gum, gum arabic, karaya Gum, locust bean gum, linseed gums, dextrans, cellulose derivatives, e.g. For example, methylcellulose, hydroxyalkylcellulose and carboxymethylcellulose, starch fractions and derivatives such as amylose, amylopectin and dextrins, clays such. Bentonite or fully synthetic hydrocolloids such as e.g. Polyvinyl alcohol, structurants such as maleic acid and lactic acid, perfume oils, dimethyl isosorbide and cyclodextrins,

Solvents and mediators such as ethanol, isopropanol, ethylene glycol, propylene glycol, glycerine and diethylene glycol, quaternized amines such as methyl-1-alkylamidoethyl-2-alkylimidazolinium methosulfate defoamers such as silicones, colorants for dyeing the agent,

Antidandruff active ingredients such as Piroctone Olamine, zinc Omadine and Climbazol, substances for adjusting the pH, such as conventional acids, in particular edible acids and bases, cholesterol,

Bodying agents such as sugar esters, polyol esters or polyol alkyl ethers, fats and waxes such as spermaceti, beeswax, montan wax and paraffins, fatty acid alkanolamides,

Complexing agents such as EDTA, NTA, β-alaninediacetic acid and phosphonic acids, swelling and penetrating agents such as glycerol, propylene glycol monoethyl ether, carbonates, bicarbonates, guanidines, ureas and primary, secondary and tertiary phosphates, opacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers Pearlescing agents such as ethylene glycol mono- and distearate and PEG-3-distearate, preservatives,

Stabilizers for hydrogen peroxide and other oxidizing agents, propellants such as propane-butane mixtures, N ₂ O, dimethyl ether, CO ₂ and air, antioxidants.

With regard to further optional components as well as the amounts of these components used, reference is expressly made to the relevant manuals known to the person skilled in the art, eg. B. Kh. Schrader, bases and formulations of the cosmetics, 2nd edition, Hüthig book publishing house, Heidelberg, 1989, referenced.

Furthermore, the products according to the invention may contain alkalizing agents, usually alkali metal or alkaline earth metal hydroxides, ammonia or organic amines. Preferred alkalizing agents are monoethanolamine, monoisopropanolamine, 2-amino-2-methyl-propanol, 2-amino-2-methyl-1,3-propanediol, 2-amino-2-ethyl-1,3-propanediol, 2-amino-2 -methylbutanol and triethanolamine and alkali and alkaline earth metal hydroxides. In particular, monoethanolamine, triethanolamine and 2-amino-2-methyl-propanol and 2-amino-2-methyl-1, 3-propanediol are preferred within the scope of this group. The use of ω-amino acids such as ω-aminocaproic acid as alkalizing agent is also possible.

The product according to the invention consists of a two-component agent a two-chamber dispenser.

Two-chamber dispensers are in principle already known in the art. In a particularly simple embodiment, they are tubes which have two separate chambers, which are designed as hoses inserted into one another. These define the inner and outer chambers and terminate in the common head or exit region. The head area is designed so that the two preparations emerge together from the tube as soon as pressure is exerted on the tube. The design of the head region can be carried out so that the preparations emerge from the tube in a specific striped pattern.

Preferably, however, the two-chamber dispenser has a pumping or spraying device. Particularly preferably, the two-chamber dispenser on two separate chambers, which are arranged together in a single rigid container and associated with at least one pump or a valve. Most preferably, each chamber is associated with its own pump or valve, but with a push mechanism that allows both pumps or valves to be activated simultaneously. This ensures that upon actuation of the pressing mechanism by the consumer preparation (A) and preparation (B) in a predetermined volume ratio emerge from the two-chamber dispenser.

The two-chamber dispenser used preferably has product outlet nozzles, which are arranged directly next to each other, so that the product strands emerging from the individual chambers are mixed directly.

The choice of the volumes of the individual chambers depends on the desired ratio of the volumes of preparation (A) and preparation (B) in the two-component agent. Preferably the volume ratio of volume of the first chamber to volume of the second chamber and thus also the volume ratio of preparation (A) to preparation (B) is 1: 0.5 to 1: 2, particularly preferably 1: 0.7 to 1: 1, third

It should be noted that it is advantageous for the function of the two-chamber dispenser if the various components present in the respective chambers each have approximately the same viscosity.

The two-chamber dispenser is preferably made of a material that is commonly used for packaging hair treatment compositions for the temporary structuring of hair. For example, dispensers of metal or metal-plastic laminate may be used. Preferably, however, plastic laminate (PE, PET, PP) or plastic coextrudate (PE, PET, PP) is used. In addition, the material of the individual chambers can be selected independently of the material of the optionally required rigid outer container.

Particularly preferred is a two-chamber dispenser is used, as described in WO 03/053814 A1.

The invention further relates to two-chamber dispensers containing in a first chamber a preparation (A) containing at least one film-forming and / or setting polymer, and in a second chamber a preparation (B) containing at least one care substance.

The particular and preferred embodiments of the two-chamber dispenser according to the invention correspond to those already described above.

The following examples are intended to illustrate the subject matter of the present invention without limiting it in any way.

Examples

The following formulations were prepared. The quantities are understood - unless otherwise stated - in percent by weight.

1 formulations of the setting phase (preparation (A))

2 formulations of the maintenance phase (preparation (B))

3 application

Firming phase and maintenance phase were packaged separately in the volume ratio 1: 1 in the two chambers of a two-chamber dispenser. For use, the two-component agent from the two-chamber dispenser was placed in the palm of the hand, mixed and then applied to human hair. An excellent curl definition was achieved, with the treated hair not feeling sticky and having a soft feel.

4 List of used products

The products used in the examples are defined as follows:

Benzophenone-4 (INCI) 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid Synthetic K acrylic acid homopolymer linked by pentaerythritol, sucrose or propylene allyl ether (INCI name: Carbomer) (3V Sigma)

PVP / VA W 635 vinylpyrrolidone vinyl acetate copolymer stabilized in water with 0.05% dodecyltrimethylammonium chloride (about 50% active content, INCI name: VP / VA copolymer) (International Specialty Products)

AMP Cosmetic Grade 2-amino-2-methylpropanol (INCI name: Aminomethyl Propanol) (Dow Chemical)

PEG-40 Hydrogenated Castor OiI: Polyethylene glycol derivative of hydrogenated castor oil with an average of 40 moles of ethylene oxide (INCI name: PEG-40 Hydrogenated Castor OiI) (BASF)

Dow ^Corning® 1501 Fluid Approx. 15% highly viscous dihydroxypolydimethylsiloxane in decamethylcyclopentasiloxane (INCI name: cyclopenta- siloxanes and dimethiconol) (Dow Corning)

Dow Corning ^® 245 fluid decamethylcyclopentasiloxane (INCI name: cyclopenta- siloxane) (Dow Corning) Dow Corning 949 ^® Aqueous Aminoethylaminopropylsiloxan dimethylsiloxane copolymer emulsion as emulsifiers

Contains cetyltrimethylammonium chloride and tridecyl alcohol ethoxylate (silicone content: about 35%, INCI name: Amodimethicone and Cetrimonium Chloride and Trideceth-12) (Dow Corning)

Dow ^Corning® 5330 Fluid Polysiloxane Polyether Copolymer (INCI name: PEG / PPG-15/15 dimet cone) (Dow Corning)

Dow ^Corning® 556 Cosmetic Grade Fluid: Polyphenylmethylsiloxane (INCI name: Phenyl

Trimethicone) (Dow Corning)

Sepigel 305 Emulsion of polyacrylamide in isoparaffin, containing as emulsifier dodecyl alcohol ethoxylate (about 45-49% polymer content, INCI name: polyacrylamide and C13-14 isoparaffin and laureth-7) (Seppic)

Claims

 claims

Product for the treatment of keratinic fibers, consisting of a two-component agent and a two-chamber dispenser, characterized in that the two-component agent comprises a first preparation (A) comprising at least one film-forming and / or setting polymer, and a second preparation (B) containing at least one care substance, and the two preparations are packaged separately in the chambers of the two-chamber dispenser. Product according to Claim 1, characterized in that the film-forming and / or setting polymer of preparation (A) is a homopolymer or copolymer composed of at least one of the following monomers: vinylpyrrolidone, vinylcaprolactam, vinylester, vinylalcohol, acrylamide, methacrylamide, Ci to C ₇ alkyl and C ₁ - to Cy-dialkyl acrylamide, Ci- to C ₇ alkyl and C ₁ - to C ₇ -Dialkylmethacrylamid, C ₁ - to C ₇ -alkyl acrylate, C ₁ - to C ₇ -alkyl methacrylate, propylene glycol and ethylene glycol. Product according to one of claims 1 to 2, characterized in that the preparation (B) contains as a care substance at least one silicone oil and / or a silicone gum. Product according to claim 3, characterized in that the preparation (B) contains at least two different silicone derivatives. Product according to Claim 4, characterized in that the silicone derivatives are selected from the group comprising cyclic and linear polydialkylsiloxanes, their alkoxylated and / or aminated derivatives, dihydroxypolydimethylsiloxanes and polyphenylalkylsiloxanes. Product according to one of claims 3 to 5, characterized in that the preparation (B) contains at least one further care substance. Product according to one of claims 1 to 6, characterized in that the preparation (A) and / or the preparation (B) contains at least one UV filter. Product according to one of claims 1 to 7, characterized in that the two-chamber dispenser comprises a pumping or spraying device. Two-chamber dispenser containing in a first chamber a preparation (A) containing at least one film-forming and / or setting polymer, and in a second chamber a preparation (B) containing at least one care substance. Two-chamber dispenser according to claim 9, characterized in that the volume ratio of the volume of the first chambers to the volume of the second chamber is 1: 0.5 to 1: 2.